Revenue increased 3% to $13.4 million.

That number, on its own, does not look particularly impressive.

But the quarter was considerably better than the top line suggests.

Gross margin increased to 59% from 56%. Adjusted EBITDA rose 28% to $4.3 million. Net income increased 51% to $2.94 million. Basic earnings per share rose to $0.013 from $0.009.

The more important development was underneath the consolidated revenue number.

D-BOX sold fewer systems, while the revenue associated with its installed base increased sharply.

That mix shift may matter much more than whether total revenue grows 3%, 10% or 20% in any individual quarter.

The Mix Was Better Than the Growth Rate

D-BOX generated $8.42 million from system sales, down 7% from $9.04 million a year earlier.

The decline was not uniform.

Theatrical system sales fell 9% to $3.70 million.

Simulation and training fell 19% to $1.76 million.

Sim racing was essentially flat at $2.32 million.

Other system sales increased 34% to roughly $647,000.

If that were the entire business, the quarter would have been fairly ordinary.

It isn’t.

D-BOX also generated $4.98 million from rights for use, rental and maintenance revenue, up 25% from $3.99 million a year earlier and the highest quarterly amount reported in the filing.

That distinction matters because the economics of those two revenue categories are different.

D-BOX first has to place its technology into theatres, racing centres and other commercial environments.

Once that installed base exists, it can generate additional licensing, maintenance, rental and royalty-related revenue from equipment already in the field.

The company had 1,233 active theatrical screens at June 30, up from 1,047 a year earlier, an increase of roughly 18%.

Management says the larger installed base, combined with stronger North American box office activity, contributed to the increase in rights-for-use, rental and maintenance revenue.

That helps explain why the income statement improved much faster than revenue.

D-BOX produced $7.92 million of gross profit on $13.40 million of revenue, compared with $7.32 million of gross profit on $13.04 million a year earlier.

Revenue increased by less than $400,000.

Gross profit increased by more than $600,000.

Gross margin improved from 56% to 59%.

Management attributes the improvement primarily to a more favourable revenue mix, particularly the higher proportion of rights-for-use, rental and maintenance revenue.

That tells us considerably more about the quarter than the 3% headline growth rate.

One Important Qualification

There is a temptation to call the entire $5.0 million category “royalty revenue.”

I don’t think the filing supports that.

D-BOX calls the category rights for use, rental and maintenance revenue.

Management says the increase was supported by higher royalty-based revenue, recurring licensing revenue and maintenance fees.

It does not provide enough detail to determine exactly how much of the $4.98 million came from each component.

That matters because different types of revenue can have different levels of predictability.

The quarter gives us evidence that this installed-base revenue category is growing quickly and carrying attractive margins.

It does not give us enough information to classify the entire amount as recurring royalty revenue.

That distinction becomes important when trying to determine how durable the earnings improvement may be.

Profitability Improved Faster Than Revenue

The revenue mix was only part of the quarter.

D-BOX also kept operating expenses under control.

Selling and marketing increased 5% to $1.77 million.

Administration declined 16% to $1.88 million.

Research and development declined 7% to $1.34 million.

Total operating expenses fell 6% to $5.04 million.

Administration benefited from lower share-based compensation and lower salaries and benefits, so the expense improvement should not simply be extrapolated indefinitely.

Still, the overall progression was strong:

• Revenue: $13.4 million, up 3%

• Gross profit: $7.9 million, up about 8%

• Adjusted EBITDA: $4.3 million, up 28%

• Net income: $2.94 million, up 51%

The operating economics improved considerably more than the revenue line did.

For shareholders, that is probably the most important part of the quarter.

Cash Flow Looked Worse

There is one number that moved in the opposite direction.

Operating cash flow fell to approximately $1.02 million from $2.83 million a year earlier.

That looks poor until the working-capital movements are separated from the underlying operating result.

Before changes in working capital, cash generated from operations was approximately $3.2 million, up materially from the comparable period.

The quarter was then affected by several uses of working capital, including higher receivables, higher inventory and lower accounts payable.

Accounts receivable increased to approximately $9.0 million from $8.4 million at March 31.

Inventory increased to approximately $6.6 million from $6.2 million.

Management attributes the receivable increase largely to the timing of revenue recognition around several late-quarter blockbuster releases and the continued expansion of the theatrical footprint.

That explanation is reasonable.

But it is still something worth watching.

One quarter of working-capital movement does not establish a problem.

It also should not automatically be treated as irrelevant.

If receivables continue increasing faster than the business, or inventory continues absorbing cash without corresponding revenue growth, the interpretation changes.

For now, the operating result before those movements was considerably stronger than the reported cash-flow comparison makes it appear.

The Balance Sheet Gives D-BOX Room

D-BOX ended the quarter with approximately $17.8 million of cash and cash equivalents against only $7.1 million of current liabilities.

Total liabilities were approximately $10.5 million, compared with equity of $37.9 million.

The company also has very little conventional debt remaining.

That gives D-BOX considerable flexibility to continue investing in the installed base without relying on near-term equity financing.

It also gives management choices about what to do with excess capital.

During the quarter, D-BOX spent approximately $386,000 repurchasing its own shares under its normal course issuer bid.

That is worth considering alongside the company’s equity compensation.

At June 30, D-BOX had approximately 15.8 million stock options outstanding, along with RSUs and SARs.

The basic share count has been relatively stable, and the company has been repurchasing shares.

But the more useful long-term measure will be whether those repurchases actually reduce the company’s economically diluted share count after compensation awards are considered.

That cannot be determined from the buyback number alone.

What I Would Watch From Here

D-BOX’s next few quarters should tell us whether this quarter represents a more durable change in the economics of the business or simply a favourable period of mix.

The first thing I would watch is the relationship between system sales and installed-base revenue.

System sales are inherently less predictable.

The theatrical business depends on exhibitor capital spending, while simulation and training can be affected by the timing of larger commercial purchases.

Those system sales still matter because they expand the population of equipment capable of producing future licensing, maintenance, rental and royalty-related revenue.

The question is whether D-BOX can continue growing that installed base while extracting more revenue from it.

The second is gross margin.

If rights-for-use, rental and maintenance revenue continues increasing as a percentage of total revenue, the company may be able to sustain better margins even during quarters when system sales are comparatively soft.

If the 59% gross margin falls back toward historical levels once the revenue mix changes again, the current quarter will look less structural.

The third is working capital.

The quarter produced strong cash generation before working-capital movements but much weaker reported operating cash flow.

Receivables and inventory should therefore be monitored over the next several periods.

The fourth is per-share economics.

D-BOX’s share count has been relatively stable while earnings have increased substantially.

That is what shareholders should want to see continue.

The Quarter Was Better Than 3% Growth Suggests

A quick reading of D-BOX’s results could produce a strange conclusion.

Revenue increased only 3%.

System sales declined.

Operating cash flow was down sharply.

All of those statements are true.

They are also incomplete.

The higher-margin rights-for-use, rental and maintenance business increased 25%.

Gross margin expanded by roughly three percentage points.

Operating expenses declined.

Adjusted EBITDA increased 28%.

Net income increased 51%.

And D-BOX finished the quarter with nearly $18 million of cash and very little debt.

The issue now is whether D-BOX can keep expanding the installed base and converting that larger footprint into higher-margin revenue without depending on unusually favorable quarterly content, mix or working-capital timing.

That is what I would use to judge the next several quarters.

A recent review of EMERGE Commerce got a surprising amount right.

The balance sheet is still weak.

Liquidity remains constrained.

Dilution is real.

The convertible matters.

The senior credit facility matters.

And despite a much better operating quarter, EMERGE has not finished repairing its capital structure.

All true.

The problem is that several of the conclusions built on top of those observations are either too aggressive, insufficiently normalized, or incomplete.

And in this case, the details matter because they change what investors should actually be watching.

What the unnamed reviewer got right

Start with the operating business.

Q2 revenue increased from $8.48 million to $9.11 million, up about 7%.

Gross profit increased almost 15% to $3.55 million.

Gross margin improved from 36.5% to 39.0%.

And operating income before the below the line items increased from roughly $524,000 to $883,000.

That is real operating leverage.

The review correctly recognized it.

It also correctly refused to treat the better quarter as proof that the balance sheet was suddenly fixed.

At June 30, EMERGE had about $4.8 million in cash, $9.1 million in current assets and $11.4 million in current liabilities.

So yes, capital structure first.

That was the right instinct.

But the liquidity numbers need labels

One of the review’s headline liquidity numbers was a current ratio of roughly 0.88x.

The reported current ratio is actually:

$9.109M current assets / $11.413M current liabilities = about 0.80x.

So where does 0.88x come from?

By removing approximately $1.08 million of deferred revenue from current liabilities.

And that is not necessarily crazy.

Deferred revenue is economically different from a conventional payable because satisfying it does not usually require writing a cheque for the full liability.

So an analyst can reasonably show an adjusted operating liquidity ratio excluding deferred revenue.

But then call it that.

The cleaner presentation is:

Reported current ratio: 0.80x

Adjusted ratio excluding deferred revenue: 0.88x

Both are useful.

They just answer slightly different questions.

The same issue appears in the approximately 0.59 quick ratio.

That number can also be reconstructed.

It appears to exclude inventory while keeping prepaid expenses in the numerator and deferred revenue out of the denominator.

The arithmetic works.

The label is the problem.

Prepaids are generally not quick assets. They cannot normally be used to pay creditors.

Using only cash and receivables gives quick liquidity closer to 0.48x on reported liabilities, or roughly 0.53x using the deferred revenue adjusted liability base. EMERGE’s liquidity is therefore arguably weaker than the headline quick ratio suggests.

This is not some devastating error.

But it matters when those ratios are subsequently used to argue how much financing the company supposedly needs.

A working capital hole is not automatically an equity raise

This is where the interpretation becomes more important than the ratios.

The review effectively identifies a multimillion dollar gap between selected liquid assets and adjusted current liabilities.

That proves something.

It proves EMERGE has liquidity pressure.

It does not prove that the same amount must be raised through equity.

Current liabilities are not one giant invoice due tomorrow morning.

Accounts payable turn over.

Inventory sells.

Deferred revenue becomes revenue.

Receivables are collected.

New sales generate new liabilities and new cash.

Meanwhile, EMERGE generated approximately $1.21 million of operating cash flow during the first six months of 2026.

So the right question is not:

How large is the accounting deficiency?

It is:

How much cash must actually leave the business, on what dates, and how much can operations produce before those dates arrive?

That is a very different calculation.

And it leads directly to the most important part of the story.

The debt has to be reconstructed, not just counted

The review correctly identifies the remaining convertible debt as important.

But knowing the balance is not enough.

You have to understand how it got there.

The debentures were materially amended in 2024.

The amendment extended maturity, changed conversion economics and created a special mechanism allowing EMERGE to deal with up to 50% of the principal.

EMERGE used it.

Roughly half of the original principal was already eliminated through share issuance.

That means the remaining convertible today is the residual portion after the 50% allocation was consumed.

That distinction is critical.

The company cannot simply repeat the exact same solution under the existing terms.

So November is a real event.

But it is not simply:

$1.3 million comes due, therefore equity raise.

The possibilities include cash repayment, voluntary conversion, another negotiated amendment, refinancing or some combination.

And that becomes even more important once you look at the second major piece of debt.

The convertible is sitting in front of a $5.85 million refinancing

EMERGE’s senior credit facility has approximately $5.85 million outstanding.

In March 2026, management amended the facility again and extended maturity to October 2027.

The interest rate remains expensive, and management explicitly says refinancing the senior debt is one of its key priorities.

That raises a question the review should have pushed harder:

Are the convertible and senior facility actually two separate problems?

Maybe.

But they may also be two stages of the same broader capital restructuring.

If management is already looking for a replacement or improved senior financing package, it is entirely reasonable to consider whether the convertible gets dealt with as part of that process.

That does not mean it will.

It means investors should think in scenarios rather than treating one financing outcome as inevitable.

The cash flow argument also needs a bridge

The review’s instinct that reported operating cash flow may overstate clean underlying cash generation is fair.

EMERGE has unusual working capital dynamics, including the Tee 2 Green inventory payment plan.

That arrangement gives the company a cash flow advantage because inventory can be sold long before the related vendor obligation is fully paid.

That is real economic value.

But it also means reported CFO should not automatically be treated as completely unencumbered recurring free cash.

Fair point.

The problem comes when a normalized cash flow conclusion is stated without showing the actual normalization.

If reported CFO is being adjusted downward because of vendor financing or working capital timing, show:

Reported CFO
less financing-assisted working-capital benefit
plus/minus temporary working-capital effects
= normalized CFO

Without that bridge, the direction may be right while the magnitude remains difficult to reproduce.

That matters when the normalized number is then used to forecast another financing.

The dilution criticism is right — but incomplete

The review was absolutely right to highlight dilution.

The March financing issued 27 million shares, plus 13.5 million $0.15 warrants and 773,000 broker warrants.

Weighted average shares increased from about 142.3 million to 176.5 million year over year.

That is significant.

But “share count went up” is only half the analysis.

The financing primarily funded the acquisition of Viral Loops and provided additional corporate liquidity.

So the real question is:

What did shareholders receive for giving up that ownership?

We do not yet have enough evidence to declare the dilution productive or destructive.

But we can say something uncomfortable already.

Q2 revenue increased about 7%.

Gross profit increased about 15%.

Weighted average shares increased about 24%.

So the company improved faster than before.

But the ownership denominator improved faster still.

That means consolidated growth has not yet translated into equivalent per share growth.

That is the stronger dilution argument.

The Viral Loops criticism goes too far

The review also takes issue with the March financing being described as acquisition related because EMERGE raised approximately $2.7 million gross while Viral Loops required about $2.1 million at closing.

That criticism is fair up to a point.

The raise did exceed the immediate closing cheque.

But the filing says proceeds were used for Viral Loops and general corporate purposes, and Viral Loops also included another $200,000 payable later.

There were also financing fees, transaction costs, integration expenses and ordinary working-capital requirements.

So the interesting question is not whether management committed some semantic crime by raising more than the closing cheque.

The interesting question is:

Was the extra dilution economically worth it?

That will be answered by what Viral Loops produces.

Not by rhetoric around the financing announcement.

Organic growth is another place where precision matters

The filing says EMERGE achieved positive overall organic growth in Q2.

It also says consolidated growth benefited from Tee 2 Green and Viral Loops.

That supports the conclusion that some of the growth was organic and some acquired.

What it does not necessarily support is an exact split unless the acquisition contribution can be reconstructed from disclosed numbers.

There is nothing wrong with estimating.

Just call it an estimate.

“Approximately half organic and half acquired” sounds factual.

If the filings do not provide the bridge, it is inference.

Small distinction.

Important habit.

Where the review was strongest

None of this should obscure what the review did very well.

It identified what matters first.

That is harder than it sounds.

A weaker review could easily spend 2,000 words congratulating EMERGE on margin expansion while barely mentioning the instruments that may determine what existing shareholders own a year from now.

The familiar review did not make that mistake.

Liquidity.

Convertible.

Senior refinancing.

Dilution.

Those are the right subjects.

And that is why the corrections matter.

When you identify the correct pressure point, you owe the reader an equally careful explanation of the mechanism.

So what really matters now?

Three things.

1. How the remaining convertible is resolved

The old 50% mechanism has already been used.

So the next resolution matters.

Cash?

Shares?

Another amendment?

A broader refinancing?

The terms will tell us more than anybody’s prediction beforehand.

2. What happens to the $5.85 million senior facility

Management is already pursuing refinancing.

That could be enormously important.

A lower borrowing cost would allow more of the company’s operating improvement to reach shareholders.

A poor refinancing could simply extend the problem at an expensive price.

3. Whether the business finally outruns the share count

The operating numbers are improving.

Now per share economics have to follow.

Revenue per share.

Gross profit per share.

Normalized earnings per share.

Free cash flow per share.

That is the scoreboard.

The Bottom Line

The familiar review got more right than wrong.

That is not faint praise.

It correctly identified the improving operating business and correctly refused to ignore the weak capital structure sitting on top of it.

But several important conclusions became less rigorous once the review moved from identifying the problem to explaining exactly how it would be resolved.

The liquidity ratios were adjusted in ways that should have been labeled more clearly.

The quick ratio treated prepaids too generously.

The working capital shortfall was pushed too directly toward a financing prediction.

The cash flow normalization was not fully shown.

The 50% convertible mechanism had already been used.

The convertible and senior facility may belong in the same broader restructuring analysis.

And dilution was identified correctly without fully asking whether the assets purchased with that dilution ultimately create enough value per share.

That leaves us with a much simpler EMERGE thesis.

The business is improving.

The capital structure is not fixed.

The next restructuring decision matters more than the next quarterly revenue number.

And the most important question is no longer whether EMERGE can grow.

It is whether management can finish cleaning up the balance sheet without giving away too much of that growth before existing shareholders finally get to keep it.

Our headline literally said “Purebread isn’t fixed”

We said the balance sheet was ugly, dilution was real, financing risk remained, and more capital could be required.

Our argument was simply that “the restructuring was changing the survival equation” And with that BRED has a significant upside if the operators scale this brand effectively. In addition, they didn’t go through this amount of work to fold it now.

(If folks don’t know who’s behind this yet) You can to Purebread Brands Inc. Announces Closing of Previously Announced Debt Settlement and dig in a bit.

Closing Of Debt Settlement

Interestingly, a recent alternative review effectively concedes that point. The previous thesis contemplated the company potentially not surviving another 12–18 months. The updated view now acknowledges that outcome is substantially less likely.

That matters.

So does what happened to the financing.

Saying much of the April raise is “already gone” sounds dramatic, but the cash flow statement shows almost $600,000 went to loan repayments and another $417,000 to lease obligations.

Paying down the very liabilities everyone is worried about is not the same thing as simply burning through a financing.

And since our original review, another important piece of the restructuring has been completed: $3 million of facility debt was exchanged for 20 million shares and 10 million warrants.

For anyone unfamiliar with the capital stack, senior secured debt sits ahead of common equity. A creditor voluntarily exchanging part of that senior claim for equity is moving down the recovery waterfall.

That does not prove the stock is going higher. It does not eliminate the risks.

But it certainly matters when assessing whether the company is simply headed for the ground.

Creditors can restructure distressed debt for many reasons, but they generally do not surrender seniority unless they see some economic benefit in the equity optionality or continued enterprise.

Again: the restructuring and people involved now changed the survival equation.

We will leave the final word to Stuart Smalley.

Sometimes the affirmation writes itself.

Stay Classy

Back to the BBQ, Enjoy the holiday Everyone.

I have zero shares, I’m simply writing this review for entertainment purposes.

Far fewer know about the restaurant group, the people and the local relationships behind the expansion of HEAL Wellness and Rosie’s Burgers into Texas.

The partner’s name did not appear in the original news release. Happy Belly described an “experienced multi-unit franchise operator” with “strong local market knowledge,” but shareholders were not told who the operator was or what experience stood behind the agreement.

Then, on October 25, 2025, CEO Sean Black provided the missing name.

While attending a Texas Tech football game in Lubbock, Black publicly thanked his hosts:

“Our franchise partners in Lubbock… Howard Restaurant Group.”

Eleven days later, Happy Belly announced that HEAL Wellness had secured its first U.S. location in Lubbock. Five days after that, the same Texas franchise group secured the first U.S. location for Rosie’s Burgers.

The pieces were public. They simply had not been put together.

Howard Restaurant Group is not simply an operator willing to open a franchise. It is connected to decades of restaurant ownership, multi-unit development and local business relationships across West Texas.

That appears to be exactly the kind of partner Happy Belly wanted for its first move into the United States.

The operator behind the agreement

Happy Belly formally announced its Texas expansion on June 5, 2025.

HEAL Wellness had signed a 10 unit development agreement with a U.S.-based QSR developer for the Greater Dallas–Fort Worth market. Sean Black emphasized the importance of putting “boots on the ground” and choosing the right local partner as Happy Belly established itself in the United States.

By November, the group had secured HEAL’s first U.S. real estate near Texas Tech University. Days later, Rosie’s Burgers was added to the same property through the same franchise relationship.

Happy Belly confirmed that its Texas partners were becoming “multi-branded operators within the Happy Belly portfolio.”

That wording deserves attention. Happy Belly had not merely found someone prepared to open a HEAL franchise. It had found an organization willing to introduce multiple Happy Belly concepts into the U.S. market.

The same operator could apply its local knowledge, restaurant experience and development relationships to more than one brand. That is where the Texas story becomes much more interesting than a conventional franchise agreement.

Meet Kendall Howard

There are restaurant franchisees, and then there are people who have spent decades building restaurant systems across multiple territories.

Kendall Howard falls into the second category.

In 2012, when Howard opened a Mama Fu’s Asian House in Lubbock, QSR Magazine described him as a 16-year restaurant-franchise veteran. By that point, he was already a franchisee of 19 Buffalo Wild Wings locations across West Texas, Oklahoma and Arkansas.

He also owned Las Brisas Steakhouse in Lubbock and served on the boards of the Lubbock Restaurant Association, Lake Ridge and University Medical Center. His community involvement extended to organizations including the Children’s Miracle Network, United Way and St. Jude Children’s Research Hospital.

Howard entered Mama Fu’s through an 11-unit development agreement covering Northwest Texas and San Antonio. That requires a different skill set from operating a single successful restaurant.

Territorial development means building a pipeline of locations, coordinating openings, establishing management depth and creating processes that can be repeated across markets. It means thinking beyond one store.

In 2018, Howard entered another multi-unit development arrangement. Lashford Howard LLC—owned by Kendall Howard together with Patrick and Tara Lashford—signed an agreement to develop 11 Newk’s Eatery restaurants across West Texas and Greater San Antonio.

The planned territory included Lubbock, Amarillo, Abilene, Midland, Odessa, San Angelo, El Paso and the San Antonio market.

The pattern is clear: Buffalo Wild Wings, Mama Fu’s, Newk’s Eatery and now HEAL Wellness and Rosie’s Burgers.

Different concepts and different formats, but the common denominator is an operator accustomed to developing restaurant brands across multiple markets.

That is precisely the type of experience Happy Belly can benefit from as it moves beyond Canada.

An active West Texas restaurant organization

Howard’s restaurant history is extensive, but this is not simply a story about accomplishments from a decade ago.

Howard Restaurant Group continues to appear in Texas restaurant-development and construction records, reflecting an organization that remains connected to the physical work of operating, maintaining and developing restaurants.

The Lubbock Chamber of Commerce also continues to list Howard Restaurant Group as part of the local restaurant business community.

Howard’s broader business network makes the partnership even more compelling.

Public corporate records associate Kendall E. Howard with Ken Howard Construction, LLC, an active Lubbock construction business listed by the Texas Association of Builders.

Together with Howard Restaurant Group’s multi-unit operating history, territorial-development experience, real-estate relationships and local connections, this creates an unusually complete development ecosystem.

Happy Belly is not entering Texas with a franchisee that must build its local infrastructure from scratch. It appears to have a partner capable of helping move its brands from site selection and construction through to opening and restaurant operations.

For a Canadian company entering the United States, that ongoing presence is significant. Howard Restaurant Group already understands the market, has local relationships and knows what it takes to operate restaurants in West Texas.

Happy Belly does not need to manufacture that experience from scratch.

Paul Fioroni and the local network

If Kendall Howard represents the restaurant-development side of the partnership, Paul Fioroni helps illustrate the depth of the local Lubbock network surrounding it.

Fioroni has been embedded in the community for decades. He played professionally for the Lubbock Cotton Kings before becoming head coach of the Texas Tech Hockey Club.

When Texas Tech announced his appointment in 2006, Fioroni made it clear that his mission extended beyond the ice. He wanted to build corporate and community partnerships throughout Lubbock.

His own words captured the approach:

“A successful team requires successful community and corporate partnerships.”

Fioroni’s relationship with Kendall Howard also predates Happy Belly’s expansion. When Howard announced the Newk’s territorial-development agreement, Fioroni publicly congratulated him.

More recently, Fioroni has appeared in activity surrounding the HEAL project near Texas Tech. The significance is not a particular title; it is the depth and history of the relationships around the expansion.

Before most shareholders knew Howard Restaurant Group was behind the project, Sean Black was already watching Texas Tech football from the group’s suite.

The phrase “strong local market knowledge” suddenly carries much more weight.

Two Lubbock locations and the Texas Tech opportunity

Happy Belly now has two identifiable HEAL locations moving forward in Lubbock.

The first is positioned near Texas Tech University and will introduce both HEAL Wellness and Rosie’s Burgers through a shared property. The second is a standalone HEAL location in another part of the city.

These are not two identical restaurants placed in similar environments.

The Texas Tech location gives Happy Belly access to a large and growing university community while introducing two portfolio brands together in the United States. The standalone location presents HEAL in a more compact format within a different Lubbock retail environment.

Together, the sites give the local operator an opportunity to establish the brand across distinct customer bases while applying the same market knowledge and operating relationships.

The university setting is increasingly compelling. Texas Tech reported a record enrollment of 45,812 students for fall 2026—an increase of more than 3,800 students in one year and growth of more than 12% over two years.

HEAL’s smoothies, açaí bowls and wellness-focused menu appear well suited to students and young professionals looking for convenient food options. Rosie’s offers a complementary concept built around smash burgers, fries, poutine and milkshakes.

One is health-focused. The other is indulgent.

Together, they broaden the appeal of a highly visible university-area property while introducing two Happy Belly concepts to the U.S. market at once.

The local execution layer

Another name appearing around both HEAL projects is Zac Howell.

Howell is a senior associate at Fairway Commercial Advisors, a commercial real-estate brokerage based in Lubbock. His involvement across both properties provides another indication that the expansion is moving through a consistent local network.

That is what “boots on the ground” looks like in practice: Howard Restaurant Group’s restaurant experience, Fioroni’s longstanding community relationships, Howell’s role within the local real-estate process and a repeat project team supporting multiple sites.

Happy Belly has not entered Lubbock as an unfamiliar Canadian company searching for its first local contact. It appears to have entered through an established restaurant organization surrounded by people who understand the city, its real estate and its business community.

That is an important distinction.

From a portfolio to a platform

The decision to add Rosie’s Burgers to the Texas Tech property may be the clearest early demonstration of Happy Belly’s portfolio strategy.

The location was larger than HEAL required. Rather than allowing that additional space to become a disadvantage, Happy Belly used it to introduce another brand through the same franchise partner.

The company turned one real-estate opportunity into a launchpad for two concepts.

That is the difference between owning a portfolio and building a platform. A platform creates infrastructure and relationships that can be reused across brands.

Happy Belly did not need to find a second Texas operator for Rosie’s or establish an entirely separate local network. The same restaurant organization, market knowledge and development relationships could support both concepts.

The next Happy Belly brand entering the market may not have to begin from zero.

One capable operator can potentially become a distribution channel for multiple concepts. One successful market entry can build familiarity with the broader portfolio. One established local network can support more than one opening.

Howard Restaurant Group is particularly compelling in this context because developing multiple restaurant concepts is already part of its history.

This is familiar territory.

What most shareholders missed

Almost nothing in this story was truly hidden.

Sean Black named Howard Restaurant Group publicly. Kendall Howard’s restaurant résumé was public. His Buffalo Wild Wings, Mama Fu’s and Newk’s history was public. Paul Fioroni’s Texas Tech background was public. The Lubbock locations, the local execution and the decision to give Rosie’s to the same franchise group were public.

Each piece appeared ordinary on its own.

Put them together and a much more important picture emerges.

Happy Belly has not merely found someone willing to open HEAL in Texas. It appears to have connected two of its brands to an established West Texas restaurant organization with decades of multi-unit experience, deep local relationships and an active development network in Lubbock.

The obvious story is that Happy Belly is entering the United States.

The more important story is how.

Through Howard Restaurant Group, Happy Belly appears to have secured something that is difficult to build quickly: an experienced local restaurant ecosystem and a potential distribution channel for multiple concepts.

Most shareholders already knew the company was heading south. They knew about the 10-store agreement, HEAL and Rosie’s.

What many may not have appreciated was the experience and local network behind the expansion.

Now the name has a history.

The history has people.

The people have relationships.

And those relationships are already carrying multiple Happy Belly brands into Texas.

Howard Restaurant Group was hiding in plain sight.

Once you understand what sits behind the name, Happy Belly’s Texas expansion looks considerably bigger—and considerably more bullish—than the original announcement suggested.

Unrelated to the US news but a major HEAL milestone, Congrats on 50 & 51!

Disclosure: The authors Veritas & MoneyMaker are supporters of Happy Belly Food Group and may own shares. This article reflects personal research and opinion and is not financial advice.

There is a very convenient way to misunderstand Sean Black.

Just say:

“He used to work at MTY.”

It sounds impressive enough.

It also gets the story backwards.

Sean Black did not arrive at MTY because Stanley Ma decided to give a promising restaurant executive a job.

Stanley Ma bought the company Sean had helped build.

In 2013, MTY Food Group paid $45 million for Extreme Brandz — the restaurant platform behind Extreme Pita, Mucho Burrito and PurBlendz.

And Stanley was not buying three names to stick on a corporate website.

He was buying a functioning restaurant system.

A development engine.

Franchise infrastructure.

And something MTY still did not meaningfully have at the time:

a foothold in the United States.

Extreme Brandz already had roughly 40 U.S. restaurants and an operating presence in Scottsdale, Arizona.

Those became MTY’s first restaurants in America.

Read that again.

Sean Black’s company did not follow MTY into the United States.

MTY followed Sean’s company in.

And Stanley Ma was smart enough to recognize that the most valuable thing he had acquired might not have been sitting on the menu board.

So after paying $45 million for the business, he kept Sean inside MTY as Chief Development Officer.

That is where this story really starts.

Because three years later, MTY made the deal that transformed its American footprint:

Kahala Brands.

Thousands of restaurants.

A massive U.S. platform.

And where was Kahala based?

Scottsdale, Arizona.

The same city where Sean’s Extreme Brandz had already helped give MTY its first meaningful American operating presence.

The point is not that Extreme Brandz caused Kahala.

That would be impossible to prove.

The point is that capability came before scale.

Stanley bought the beachhead.

He kept the operator.

He learned the market.

Then he sized up.

That was Stanley Ma at his best.

And Sean Black was inside the machine while it happened.

Then Sean left.

And he did what builders tend to do.

He built again.

Through Crave It Restaurant Group, Sean and his partners helped develop The Burger’s Priest, which eventually ended up inside Recipe Unlimited.

Now the pattern becomes difficult to ignore.

Sean helps build Extreme Brandz.

MTY buys it.

Sean helps build The Burger’s Priest.

Recipe Unlimited ends up owning it.

Two restaurant groups.

Two major strategic buyers.

Two examples of assets Sean helped build becoming valuable enough for much larger restaurant companies to want them.

And this is where the story becomes particularly relevant to Happy Belly shareholders.

For most of Sean Black’s career, he was helping build value inside vehicles that ultimately belonged to somebody else.

Stanley’s machine.

Recipe’s portfolio.

Other people’s balance sheets.

Other people’s shareholders.

Happy Belly changes that.

For the first time, Sean Black has a public vehicle where he is not simply building the asset somebody else may eventually buy.

He is building the machine that does the buying.

That is a completely different proposition.

And it creates a much more interesting investment question than:

Will Heal be successful?

Or:

How many Rosie’s can they open?

Or:

Can Happy Belly get to 100 restaurants?

Those matter.

But they are downstream questions.

The bigger question is:

What happens when a man who has spent decades building restaurant assets other sophisticated restaurant operators wanted to own finally gets to allocate the capital himself?

That is the Happy Belly thesis.

And understanding it requires understanding three files.

The restaurant file comes from Stanley Ma.

The U.S. file comes from Sean Black himself.

The price file comes from Fairfax.

And Eric Lefebvre?

Eric is useful for a different reason.

He is the warning label.

Stanley Ma Did Not Build a Restaurant Company

He built a machine.

That distinction matters.

Stanley’s genius was never really about food.

It was architecture.

Find a concept.

Understand the box.

Pay a price that makes sense.

Develop it.

Franchise it.

Centralize what should be centralized.

Let operators operate.

Collect royalties.

Recycle capital.

Repeat.

Eventually the machine becomes more valuable than any individual restaurant banner sitting inside it.

That was MTY.

The banners changed.

The system survived.

And the system worked because Stanley understood something acquisition-hungry executives routinely forget:

Getting bigger is not the strategy.

Getting better at allocating capital is the strategy.

Scale is supposed to be the result.

Not the input.

Stanley did not need the biggest transaction in the room.

He needed transactions that made the machine stronger.

Extreme Brandz is a perfect example.

It brought brands.

It brought operators.

It brought U.S. exposure.

It brought development capability.

And Stanley retained Sean Black inside MTY after the acquisition.

That is not a footnote.

That is part of the asset.

Great allocators do not need to invent every capability internally.

Sometimes the smartest move is buying people who already know something the company wants to know.

Stanley understood that.

Extreme Brandz Was the Beachhead

Then came Kahala.

And this is where the chronology matters.

2013: Extreme Brandz.

First meaningful U.S. restaurant exposure.

Scottsdale infrastructure.

Sean Black retained.

Then:

Experience.

Development.

Learning.

Operating.

Understanding what travels.

Understanding what does not.

Three years later:

2016: Kahala Brands.

A completely different level of scale.

MTY said the deal added 2,879 locations to the system.

That was not crawl.

That was run.

But the run came after the crawl.

That is the lesson.

Capability first. Scale second.

You do not cleanly absorb a massive U.S. restaurant portfolio because a banker puts together a beautiful deck.

You learn the market first.

The franchisee.

The real estate.

The customer.

The labour model.

The concepts that travel.

The ones that do not.

Then, when the opportunity is large enough and the capability strong enough:

you size up.

That is what Stanley understood.

And that is the restaurant file Sean had a front-row seat to.

Then Eric Got the Keys

Eric Lefebvre was not some outsider who arrived after the education was over.

He was MTY’s CFO from 2012 through 2018.

He was there for Extreme Brandz.

He was there for Kahala.

He saw the machine work.

Then Stanley stepped down as CEO.

Eric took over.

Five months later came Papa Murphy’s.

And this is where the philosophy begins to look different.

Eric Bought Scale

Papa Murphy’s looked terrific on a slide.

America.

Pizza.

More than 1,400 locations at year-end 2018.

Roughly US$809 million in system sales.

The fifth-largest pizza chain in the United States.

And the presentation called it an:

“Exciting New Growth Platform.”

There is that word.

Platform.

MTY agreed to a transaction valued at approximately US$190 million including net debt.

Papa Murphy’s had generated about US$22.3 million of trailing adjusted EBITDA.

That works out to roughly 8.5× EBITDA.

Can 8.5× work?

Of course.

That is not the criticism.

The criticism starts after you pay it.

Because this is the part too many acquisition stories conveniently separate:

The purchase price is part of the operating plan.

You do not get to pay a full price today and then treat tomorrow’s operating problems as though they exist in a different universe.

The price determines how much execution is required.

How much growth.

How much turnaround.

How much margin improvement.

How much time.

The higher the price, the less room there is to be wrong.

And if an acquisition later requires years of turnaround work, impairment charges, shrinking store counts or explanations about why the original economics will eventually make sense, shareholders are allowed to go back to Day One and ask:

Where was the margin of safety?

That is not hindsight.

That is capital allocation.

Then Came More Scale

MTY kept buying.

BBQ Holdings.

Wetzel’s.

More U.S. scale.

More system sales.

More brands.

More capital committed.

And every individual deal can be defended.

That is the beauty of acquisition decks.

Almost every transaction looks reasonable when presented one at a time.

The more revealing view comes when the transactions are put together.

At what point does getting bigger quietly become the strategy?

That is where Stanley and Eric begin to separate.

Stanley used scale as the output of good capital allocation.

Under Eric, scale increasingly looks like the input.

Buy another platform.

Add more sales.

Add more brands.

Add another acquisition slide.

Build more infrastructure.

Then justify the infrastructure with another acquisition.

Eventually the company becomes so committed to being a platform that the word itself starts replacing the investment case.

That is how acquisition culture changes.

First comes a deal.

Then a platform.

Then strategic scale.

Then transformational scale.

Then another deal to justify the cost base created by the previous deal.

At some point management stops asking:

What is the best use of the next dollar?

And starts asking:

What do we have to buy next to keep the story moving?

That is when capital allocation turns into narrative maintenance.

And that is dangerous.

This Is Where Fairfax Matters

Not because Happy Belly is Fairfax.

It is not.

Not because Sean Black is Prem Watsa.

He is not.

And not because Recipe Unlimited is the model.

It is not.

The useful comparison is temperament.

Strip away Fairfax’s insurance complexity and the capital-allocation lessons are simple.

Know the circle.

Operate where the economics are genuinely understood.

Back operators you trust.

Give them room.

Keep enough balance-sheet strength to act when other people cannot.

Think in years.

And above all:

Pay a price that still works if the future is only fine.

Not heroic.

Not perfect.

Fine.

That sounds simple.

It is not.

Because markets reward activity.

Bankers reward activity.

Promoters reward activity.

CEOs are constantly rewarded for getting larger.

But size does not automatically create value.

Revenue is not automatically progress.

System sales are not automatically progress.

Store count is not automatically progress.

Enterprise value is not automatically progress.

Another acquisition is not automatically progress.

Per-share value creation is progress.

And if the future has to be heroic to justify the price paid?

Success was prepaid.

That is the Fairfax file.

Sean Learned the Seller’s Side Too

Sean has not only spent years inside an acquirer.

He has also spent years building assets somebody else eventually wanted.

That creates a different perspective on value.

He knows what strategic buyers look for.

He knows what makes a concept travel.

He knows what a clean restaurant box looks like.

He knows what franchise infrastructure can be worth.

He knows what scale looks like before it becomes obvious.

And he has repeatedly spent time on the side of the table where a business has to become attractive enough for somebody else to pay for it.

Now he sits on the buyer’s side.

And Happy Belly gives shareholders the opportunity to watch whether those lessons show up in how capital is deployed.

Heal is where they become visible.

Heal Is the Deal That Explains Happy Belly

Forget the size.

Focus on the structure.

Heal was tiny.

That is exactly why it is useful.

With a small transaction, management’s instincts can be seen without the noise of a giant acquisition presentation.

Sean did not write a giant cash cheque.

He did not buy 100% immediately.

He did not announce a transformational platform.

Happy Belly entered through a JV.

The founders stayed economically involved.

Happy Belly’s original investment consisted of 2,777,777 HBFG shares valued at nine cents each.

Total value:

$250,000.

Non-cash.

And beside that interest sat the most important part of the structure:

a call option on the remaining 50%.

That is the deal.

Not the bowl chain.

The structure.

Sean did not pay today for everything Heal might become tomorrow.

He bought exposure.

He kept the operators.

He preserved the upside.

He preserved the option.

Then he waited for evidence.

Half now.

Proof first.

Option later.

That is not trophy hunting.

That is underwriting.

Then Heal Had to Earn the Next Dollar

This is where Stanley’s restaurant playbook and Fairfax’s price discipline meet.

Heal had to prove itself.

Happy Belly later said the business grew for three years using only cash flow generated by Heal, without requiring Happy Belly capital.

That matters.

The public company was not functioning as an ATM for a bowl chain.

The public company structured the opportunity.

Then the operating business financed the proof.

Heal grew from two locations to 20 locations by May 2025.

Six corporate.

Fourteen franchised.

Estimated trailing EBITDA reached approximately $750,000, compared with around $230,000 of projected forward EBITDA near the original transaction.

The concept earned the right to grow.

That is Stanley:

Build boxes that work before you build lots of boxes.

And wrapped around it is the Fairfax lesson:

Do not pay today for success that still has to happen tomorrow.

Then Sean Pulled the Call

October 9, 2025.

Happy Belly acquired the remaining 50% of Heal.

The agreed purchase price:

$3,896,948.

Debt-free.

The pricing framework had been set at approximately 3.75× trailing EBITDA.

But the settlement structure is where the story gets interesting.

Happy Belly did not suddenly drain nearly $4 million from treasury.

The original 2,777,777 HBFG shares sitting inside the JV became part of the consideration.

Then Happy Belly issued another 613,469 shares from treasury at a deemed value of $1.1196 per share.

Look at the sequence.

In 2022:

HBFG shares worth nine cents go into the structure.

The founders stay involved.

Happy Belly gets exposure.

Happy Belly gets a call.

Heal operates.

Heal grows.

Heal funds its own proof.

Then, three years later, the shares already inside the original structure help complete the acquisition.

No giant Day One cheque.

No trophy bid.

No giant debt package.

No need to pretend the transaction is bigger than it is.

The first deal did not just buy half of Heal.

It created the machinery for the second deal.

Sean was not paying for certainty.

He was paying for the right to learn.

That may be the most important capital-allocation idea in the entire transaction.

Do not buy the forecast.

Buy the right to watch the forecast become true.

Then pay more when the evidence improves.

Now Compare the Temperament

This is why Eric belongs in the article.

Not because MTY is bad.

Not because Happy Belly is automatically good.

Eric matters because his chapter shows Happy Belly shareholders exactly what Sean cannot afford to become.

The contrast is simple.

Eric’s model increasingly looked like:

Pay upfront for scale.

Integrate it afterward.

Manage the assumptions.

Explain the consequences.

Sean’s model, so far, looks more like:

Buy partial exposure.

Keep the founder.

Let the economics develop.

Let the operating business finance proof where possible.

Retain an option.

Commit more capital when the evidence gets better.

That is the distinction.

Not:

Big company versus small company.

Not:

MTY bad, Happy Belly good.

The real questions are:

What problem are you paying to solve?

When are you paying for it?

Who stays economically aligned?

What happens if you are wrong?

How much optionality remains?

Those are the questions that determine whether an acquisition creates value or merely creates headlines.

The Consumer Did Not Sign the Purchase Agreement

Yes, restaurants have faced a difficult consumer environment.

Inflation matters.

Labour matters.

Interest rates matter.

Traffic matters.

Disposable income matters.

Nobody serious disputes any of that.

But weak consumers did not make MTY buy Papa Murphy’s.

Weak consumers did not choose the price.

Weak consumers did not buy BBQ Holdings.

Weak consumers did not choose the financing structure.

Those were management decisions.

And that means they belong in the capital-allocation record.

The weather tests the price.

It does not excuse it.

If a transaction only works when consumers stay strong, rates cooperate, execution is perfect and the turnaround arrives exactly on schedule...

the margin of safety was probably never very large.

Now MTY Is Closing the Boxes

This is where the current chapter gets uncomfortable.

MTY is closing 68 underperforming corporate restaurants.

Those restaurants collectively generated more than $10 million in losses over the preceding twelve months, and MTY expects another $10–12 million in closure-related costs.

Closing bad restaurants is not the mistake.

Keeping them open would be worse.

The question is how they got there.

Management selected the assets.

Management selected the price.

Management selected the financing.

Management selected the leverage.

The consumer can expose weak economics.

The consumer did not sign the purchase agreement.

And now MTY is also in a strategic review.

Maybe that process ultimately creates shareholder value.

Entirely possible.

But the nature of the questions has changed.

Stanley spent decades asking:

What can we build next?

The current chapter increasingly asks:

What should we do with what we already built?

Those are not the same questions.

Stanley built the map.

Eric inherited it.

And now the board has a banker helping decide what the map is worth.

That is a very different chapter.

MTY’s Risks Are Starting to Look Like Autopsy Risks

The distinction is becoming difficult to miss.

Happy Belly’s risks are mostly forward-looking.

Can Heal travel?

Can Rosie’s travel?

Can franchisees make money?

Can the unit economics hold in the United States?

Can Sean maintain discipline as the company becomes larger?

Those are execution risks.

MTY increasingly has backward-looking questions.

What did we buy?

What did we pay?

Why did it shrink?

Why did it impair?

Which stores should close?

How much optionality did leverage consume?

What should be sold?

What is the whole thing worth to somebody else?

Those are autopsy risks.

And that is not where a compounder wants to end up.

Then There Is Ownership

Alignment matters.

Stanley Ma still owns 3,175,643 MTY shares.

Roughly 14% of the company.

Eric’s direct common-share ownership has historically been tiny by comparison.

That does not automatically make Eric a bad CEO.

Plenty of professional managers create value.

But when the subject is capital-allocation psychology, ownership matters.

One man built the compounder.

Decades later, he still owns a meaningful piece of it.

The other is a professional manager with compensation, incentives and comparatively little direct common equity.

Those are different economic relationships with the company.

And shareholders are allowed to care.

But Eric Is Not the Investment Case

This is the pivot.

Eric is not the thesis.

Sean is.

Eric matters because he shows what Happy Belly must never become.

Happy Belly cannot start needing acquisitions.

It cannot confuse system sales with shareholder value.

It cannot let leverage consume tomorrow’s opportunities.

It cannot allow “platform” to become its personality.

It cannot spend the next decade explaining why yesterday’s price will eventually make sense.

The investment case is that, so far, Sean appears to be behaving differently.

Smaller concepts.

Founder operators.

Partial ownership.

Franchising.

Equity alignment.

Asset-light development.

Call options instead of trophy bids.

Capital committed in stages.

Operating businesses earning the right to receive more capital.

That is exactly what shareholders should want to see before a company gets large.

And Now Sean Is Going Back to America

This may be the most underappreciated part of the Happy Belly story.

Happy Belly is not merely talking about U.S. expansion anymore.

Heal signed a 10-unit development agreement for Dallas–Fort Worth with a U.S.-based QSR developer.

Heal then signed its first U.S. franchise agreement and secured real estate in Lubbock, Texas, near Texas Tech.

Rosie’s Burgers has also secured its first U.S. real estate in Texas, with the same multi-unit franchise group expanding across Happy Belly concepts.

And Sean has explicitly pointed back to his Extreme Brandz and MTY experience developing brands into the United States.

That matters.

Because this is not:

Canadian CEO discovers America on a map.

Sean has already done this movie.

The first time, the company he helped build brought MTY its first U.S. restaurants.

Stanley bought the beachhead.

Stanley kept Sean.

MTY learned.

Then MTY sized up.

Now Sean is crossing the border again.

Except there is one enormous difference.

This time, it is Sean’s vehicle.

MTY Did Not Create Sean’s First U.S. Experience

Sean’s company helped create MTY’s.

That deserves to be said clearly.

And it is why Stanley deserves praise.

Stanley saw capability.

He bought it.

He retained it.

He learned from it.

Then he scaled it.

That is what a great allocator is supposed to do.

He did not need to pretend MTY invented everything itself.

Sometimes the best move is acquiring the person who already knows something the company wants to know.

And when Extreme Brandz arrived with American restaurants and Scottsdale infrastructure, Stanley had the good sense to recognize that the asset was larger than the brands on the menu board.

That is why Kahala sits downstream of Extreme Brandz in this story.

Not because Extreme Brandz caused Kahala.

Because:

Capability compounds too.

Happy Belly Does Not Need to Become 2026 MTY Faster

This may be the most important sentence in the entire article.

Happy Belly does not need to race toward MTY’s present size.

It needs to stay early MTY longer.

Stay small enough that the next transaction matters.

Stay close enough to the restaurant that management still understands the box.

Stay close to the operators.

Stay boring about price.

Keep the balance sheet capable of offence.

Use equity when alignment makes sense.

Use JVs when buying 100% means paying for uncertainty.

Use calls when they preserve upside without forcing premature commitment.

Let operating cash finance proof whenever possible.

Buy evidence instead of forecasts.

Then size up when the capability has been earned.

That is the Stanley file.

That is the Fairfax file.

And that is what Sean needs to protect.

Because one day, if Happy Belly succeeds, somebody is going to walk into Sean Black’s office with a beautiful presentation.

The deal will be enormous.

The synergies will be impressive.

The banker will probably call it something like:

TRANSFORMATIONAL U.S. GROWTH PLATFORM

And that will be the moment that matters.

Because the biggest risk is not that Sean fails to become Stanley.

The biggest risk is that one day Sean becomes Eric.

That scale starts meaning progress.

That acquisition becomes identity.

That the slide starts driving the strategy.

That “platform” becomes the personality.

That is how the compounder becomes the brochure.

Three Files

Strip everything else away and the Happy Belly thesis comes down to three files.

The Restaurant File Comes From Stanley

Find good concepts.

Understand the box.

Franchise them.

Centralize what creates leverage.

Stay close to operators.

Let the economics earn the next dollar.

Recycle capital.

Repeat.

The U.S. File Comes From Sean

Extreme Brandz already had American restaurants before MTY bought it.

Sean was part of the team that built that foothold.

Stanley retained him.

Sean spent years inside MTY as Chief Development Officer.

Now Happy Belly is entering Texas with an operator who has already crossed this border before.

The Price File Comes From Fairfax

Know the circle.

Back operators.

Stay boring about price.

Do not require perfection.

Protect the balance sheet.

Think in years.

Do not confuse activity with progress.

And never let the banker’s definition of “platform” become your personality.

Put all three together and the Happy Belly architecture starts to become visible.

Happy Belly is not running two versions of MTY. Sean Black is running Stanley’s restaurant playbook and Fairfax’s capital-allocation playbook. Eric is what happens when you forget the second manual.

That is the thesis.

Not that Happy Belly is already MTY.

It is not.

Not that Sean has earned Stanley Ma’s record.

He has not.

Not that Happy Belly is Fairfax.

That would be absurd.

The point is simpler.

Architecture appears before scale.

And the architecture is becoming visible.

So What Are We Actually Investing In?

Maybe Heal becomes enormous.

Maybe Rosie’s.

Maybe Yolks.

Maybe Via Cibo.

Maybe the most important future brand is one Happy Belly does not even own today.

Nobody knows.

And that may be the wrong question anyway.

Stanley Ma’s greatest asset was never a single restaurant banner.

It was the machine that kept finding, acquiring and developing them.

Fairfax’s greatest asset is not one subsidiary.

It is the temperament deciding where the next dollar goes.

Sean Black now has the opportunity to combine those two ideas inside his own public vehicle.

Can he keep Stanley’s restaurant instincts?

Can he use the U.S. knowledge he already accumulated?

Can he remain disciplined enough about price?

Can he preserve the balance sheet?

Can he keep founders aligned?

Can he keep buying proof instead of forecasts?

Can he keep using options instead of trophies?

And when Happy Belly eventually becomes large enough that somebody puts a billion-dollar “platform” in front of him...

Can he still say no?

That is the investment question.

Because the restaurant industry already has an Eric chapter.

Shrinking assets.

Store closures.

A strategic review.

A banker.

Happy Belly does not need to recreate that ending.

It needs to remember how the story started.

Stanley built the restaurant machine.

Fairfax supplied the temperament.

Sean helped bring MTY its first American beachhead.

And after years of helping build value inside other people’s machines...

Sean Black finally has his own vehicle.

Continue the Conversation

Join the free Stock Avengers Discord for ongoing HBFG discussion, follow-ups and analysis of other stocks:

Join Our DIscord

This article is a collaboration of research and writing from 𝐕𝐞𝐫𝐢𝐭𝐚𝐬 & $MONEYMAKER$ 🕊 🕊 If you enjoy, Thank them in Discord!

There is a habit I have been trying to eliminate from my own investing.

A company I like reports earnings. I open the release and immediately start looking for confirmation.

Revenue up.

Good.

Adjusted EBITDA improving.

Better.

Cash balance higher.

Great.

New stores, new distribution, new customers, another acquisition, another contract.

Bullish.

The problem is not that any of those numbers are necessarily wrong.

The problem is that a financial statement can contain entirely accurate numbers and still leave you with the wrong understanding of the business if you give the wrong numbers too much weight.

That is the central lesson I took from Thornton O’Glove’s Quality of Earnings.

The book was published in 1987, so you obviously cannot take every accounting convention and transplant it directly into a 2026 Canadian IFRS environment. But its analytical framework has aged remarkably well. O’Glove spends entire chapters on shareholder communications, differential disclosure, non operating and non recurring items, changes in expenses, receivables, inventories, debt, cash flow and accounting changes.

The underlying question running through all of it is remarkably simple:

What is actually happening inside the business?

Not:

What did management headline?

Not:

What did somebody on X say?

Not:

What multiple does Yahoo Finance show?

And not even:

What was reported EPS?

The real question is:

Why is that number what it is, how repeatable is it, and what does it tell me about the economics of the company?

For Canadian microcaps, I would take that framework one step further.

We need to analyze not only the quality of earnings, but also the quality of financing, quality of dilution and quality of growth.

Because on the Venture and CSE, those things can determine the investment outcome just as much as the income statement.

And two companies I follow closely Happy Belly Food Group and Glow LifeTech illustrate why this type of analysis does not have to be a hunt for bad news.

Sometimes the deeper you dig, the more interesting the thesis becomes.

Quality of earnings does not mean “find something wrong”

This is an important distinction.

Forensic accounting can become an ideological exercise if you aren’t careful.

You can convince yourself that every non GAAP number is bullshit, every warrant is bad, every increase in receivables is suspicious and every management statement is promotional.

That’s not analysis.

That’s just cynicism wearing a spreadsheet.

The goal should be to separate three things:

Reported accounting results.

Management’s explanation of those results.

The economic reality underneath both.

Sometimes the accounting result flatters the business.

Sometimes it makes the business look worse than its recurring economics.

Sometimes an expense is very real but genuinely non recurring.

Sometimes dilution destroys shareholder value.

And sometimes dilution occurs only after shareholders have already experienced substantial value creation and then brings meaningful cash into the company.

Context matters.

Happy Belly is a very good example.

Happy Belly Food Group: the IFRS loss does not tell the whole story

If you looked only at Happy Belly’s Q2 2026 IFRS income statement, you could come away with a very strange impression of the quarter.

The company reported a $4.62 million loss from continuing operations in Q2.

That is a reported fact.

But now look at what was happening operationally.

Happy Belly generated $28.4 million of QSR system wide sales, up approximately 75% from $16.2 million a year earlier and approximately 47% sequentially. The system reached 95 operating restaurants, up roughly 53% from 62 a year earlier.

Reported Q2 revenue increased approximately 57% to $8.5 million, while royalties and franchise fees increased approximately 129% to $1.6 million.

Adjusted EBITDA increased to approximately $720,000, or an 8.5% margin, from approximately $510,000 in the comparable quarter.

Cash stood at approximately $12.0 million at June 30, compared with about $3.0 million one year earlier. Those are reported figures from Happy Belly’s Q2 2026 MD&A, page 2.

So how do we reconcile a business producing those operating numbers with a $4.6 million IFRS loss?

This is exactly where Quality of Earnings becomes useful.

Start with the $4.08 million share-based compensation charge

Happy Belly recorded approximately $4.08 million of share based compensation in Q2 and approximately $8.19 million during the first six months of 2026. Those expenses are included in the company’s IFRS results. Happy Belly Q2 2026 financial statements, page 5.

The approximately $8.19 million recognized in H1 2026 does not principally represent the older Phase I securities being written off as they were exercised. Those Phase I exercises issued shares and brought cash into treasury. The large share based compensation charge recorded in the income statement instead relates to the newer Phase II performance awards, which generally carry a $2.00 exercise price and vesting conditions tied to business performance and share-price milestones extending from $3 to $10.

Under IFRS 2, Happy Belly does not wait until the share price milestones are achieved, or until the awards vest or are exercised, before recording the accounting expense. The estimated grant date fair value is recognized over an estimated five year service period using graded vesting, producing a front loaded expense profile. Happy Belly projects approximately $15.04 million of Phase II SBC in 2026 and approximately $35.99 million cumulatively through 2030. The expense is a genuine accounting cost and the potential dilution is real, but it is not a recurring cash operating cost of the restaurant business.

That expense should not simply be ignored.

Equity belongs to shareholders. Issuing equity based compensation has an economic cost.

But neither should we pretend Happy Belly’s restaurants wrote a $4.08 million cheque during Q2 to pay it.

The IFRS loss and Adjusted EBITDA are answering two different questions.

The IFRS statement asks:

What accounting costs were attributable to shareholders during the period?

Adjusted EBITDA is attempting to answer:

What did the recurring operating business produce before certain non-cash and non-recurring items?

A serious investor should understand both.

Choosing whichever number supports your existing opinion is precisely what we are trying to avoid.

Then there is the $674,008 Employer Health Tax

This is the part that deserves much more attention than I initially gave it.

Included within Happy Belly’s salaries and wages for the period was $674,008 of Employer Health Tax, or EHT, generated by gains realized when stock options and warrants were exercised.

The company explicitly identifies the EHT as non recurring, stating that it arose specifically from those equity exercises and is not reflective of normal ongoing operating activity. Happy Belly Q2 2026 financial statements, Note 18, page 23.

This isn’t imaginary.

It’s a real expense.

But it is also analytically different from paying restaurant employees, rent, food costs or recurring head office salaries.

And the event that produced that tax is where the story gets considerably more interesting.

Happy Belly’s Phase 1 warrants were built around performance

Back in June 2021, when the company was still Plant&Co — it entered into a strategic advisory arrangement that included 27 million advisory warrants exercisable at $0.20.

This was not simply 27 million warrants vesting because management managed to remain employed long enough.

Of those 27 million, 5.2 million vested upon closing of the original private placement.

The remaining 21.8 million were tied to progressively higher market-price hurdles:

$0.50.
$0.75.
$1.00.
$1.50.
$2.00.

The closing share price on the CSE had to reach those respective levels before the corresponding tranches vested.

That distinction is enormously important.

It means most of those original warrants were not earned simply because the calendar moved forward.

Shareholders had to experience substantial share price appreciation before the majority of the awards could vest.

That doesn’t make the eventual dilution disappear.

But it changes the economic bargain.

Dilution is not one single thing

Microcap investors tend to discuss dilution as though every additional share has identical economics.

It doesn’t.

Consider two hypothetical companies.

Company A is running out of cash. Its share price has collapsed. Management announces a deeply discounted placement with half warrants attached because it has no other way to fund operations.

Company B creates performance incentives when its shares are trading in the teens. Those incentives vest only after the company’s share price crosses successively higher thresholds, culminating at $2.00. The holders then have to put cash into the company to exercise those securities.

Both companies issued more shares.

Those are not economically equivalent events.

Happy Belly’s Phase 1 structure looks much closer to Company B.

In its June 19, 2026 announcement, Happy Belly reported that 100% of the performance warrants and options expiring June 18 had been exercised, completing what management called Phase 1 of its strategic growth and self-funding plan.

The company said approximately 31 million performance options and warrants had been exercised since January 2026, putting approximately $8.35 million directly into treasury.

And the subsequently filed financial statements give us another useful reconciliation.

Through June 30, Happy Belly reported $3.392 million of proceeds from option exercises and $5.963 million from warrant exercises, or approximately $9.35 million combined from all option and warrant exercises during the first half. Happy Belly Q2 2026 financial statements, page 7.

The numbers are slightly different because the June 19 Phase 1 announcement refers specifically to the Phase 1 securities it was discussing, while the June 30 financial statements capture total exercise proceeds during the full six month reporting period.

That is exactly the sort of reconciliation investors should be doing.

Is that shareholder friendly dilution?

I think the defensible answer is:

It is unusually shareholder aligned dilution by microcap standards.

But shareholder aligned.

Why?

Because the sequence matters.

The share price first had to appreciate enough for the performance conditions to be achieved.

Then the awards vested.

Then the holders still had to pay their exercise prices.

Then that exercise capital went into Happy Belly’s treasury.

So instead of:

financial distress → cheap financing → shareholder dilution

the Phase 1 mechanism was largely:

shareholder value creation → performance vesting → exercise → additional treasury capital.

That is a materially different capital formation model.

And it matters when interpreting the dilution, the exercise proceeds and the separate accounting charges associated principally with the Phase II awards.

Phase 2 takes the same idea much further

Happy Belly has since established a Phase 2 compensation structure with new performance options and warrants carrying a $2.00 exercise price and vesting conditions tied to both business performance and share price milestones extending from $3- $10 per share.

The company says those awards also require continued business performance, including growth in royalty/franchise income and sustained positive Adjusted EBITDA. At full vesting and exercise, management says executives and directors would have to invest more than $60 million back into Happy Belly.

That $60 million is a management projection of what full exercise could produce, not guaranteed future capital.

The $10 share price objective is obviously not guaranteed either.

But the incentive architecture exists today.

And from an alignment perspective, I would much rather see management build compensation around:

“We get substantially rewarded if shareholders get substantially rewarded first”

than:

“Here are millions of cheap shares regardless of what happens.”

That distinction belongs in any serious analysis of HBFG’s share-based compensation.

So what is actually happening underneath Happy Belly’s accounting loss?

Once the accounting noise is identified, the operating question becomes much clearer.

Happy Belly’s Q2 product sales were approximately $6.42 million, while franchise revenue reached approximately $1.60 million. The company reported 95 operating QSR locations, compared with 62 in Q2 2025. Its quarterly operating metrics show royalty and fee revenue rising alongside the expanding restaurant base. Happy Belly Q2 2026 MD&A, page 8.

That franchise revenue matters.

A company that has to own every incremental restaurant itself requires one kind of capital structure.

A company that can increasingly earn recurring royalty revenue from stores funded and operated by franchisees potentially has a very different scaling profile.

Management describes its strategy as franchise led and asset light.

That is a management assertion.

But the growth in royalty and franchise fee revenue provides actual reported evidence we can use to test whether the strategy is beginning to appear in the numbers.

My analytical inference is therefore not:

“HBFG’s accounting losses don’t matter.”

They do.

It is:

HBFG’s reported loss contains substantial equity compensation and one time EHT costs that should be separated from the recurring economics of its rapidly expanding QSR and franchise platform. The key proof point now is whether royalty growth and system scale begin producing increasingly visible operating leverage.

That’s a far more useful conclusion.

Glow LifeTech: a different version of improving earnings quality

Glow LifeTech provides another example, but the story is completely different.

Glow is much smaller.

It isn’t building a national restaurant platform.

The question here is simpler:

As revenue grows, is the business actually moving toward economic breakeven?

The latest numbers say it is moving in that direction.

In Q2 2026, Glow generated $522,968 of revenue, up approximately 20% from $436,325 a year earlier.

Gross profit increased to $328,309 from $293,141.

Now look at expenses.

Total expenses fell to $481,490 from $675,869.

The operating loss therefore narrowed dramatically to $153,181 from $382,728, while the quarterly net loss improved to $139,217 from $371,566.

Through the first six months, revenue increased to approximately $1.17 million from $915,000, while the six-month net loss narrowed to just $198,081 from $519,174. Glow Q2 2026 interim financial statements, page 4.

That is what I want to see in an early-stage microcap.

Not merely:

Revenue up.

But:

Revenue up.
Gross profit dollars up.
Expenses down.
Operating loss down.
Net loss down.

That is the beginning of operating leverage.

Glow’s cash flow provides another confirmation point

Glow’s Q2 MD&A reports $3,852 of positive cash flow from operating activities during Q2 2026, an improvement of approximately $35,000 from the comparable quarter.

That’s obviously not enough money to celebrate by itself.

The number is tiny.

But crossing from negative to slightly positive quarterly operating cash flow while simultaneously growing revenue is directionally important.

Glow also reported that its Q2 EBITDA loss narrowed approximately 46% to $89,145 from $164,900.

Working capital improved to approximately $1.81 million, while its current ratio increased to approximately 2.62x. Glow Q2 2026 MD&A, pages 5–6.

Again, none of those numbers individually proves sustainable profitability.

Together, however, they form a pattern.

And the pattern is what matters.

Glow also quietly cleaned up something I care about enormously: the warrant overhang

There is another quality-of-capital point here.

At the beginning of 2026, Glow still had a substantial warrant structure outstanding.

By June 30?

Zero warrants remained outstanding.

During the first six months, approximately 10.9 million warrants were exercised, bringing approximately $544,913 into the company, while approximately 39 million additional warrants expired. Glow Q2 2026 financial statements, pages 5 and 25.

Glow’s MD&A goes further and says that, across the prior three quarters, more than 70 million warrants had been eliminated, leaving the company warrant-free at quarter-end.

That matters to me.

A warrant overhang creates potential future dilution and can affect how a microcap trades.

Once those warrants are exercised or expire, that uncertainty disappears.

Glow’s share count did increase as warrants were exercised again, dilution is dilution but the company also received exercise capital, strengthened its cash position and eliminated the future warrant overhang.

At June 30, cash stood at approximately $1.60 million, compared with $1.37 million at December 31, while total current liabilities had declined to approximately $1.11 million from $1.20 million. Shareholders’ equity increased to approximately $3.07 million from $2.71 million. Glow Q2 2026 financial statements, page 3.

That’s a healthier capital structure than the one Glow entered the year with.

But this is where discipline still matters

Being bullish on a company does not mean pretending every number is perfect.

Glow’s Q2 gross margin was approximately 63% versus 67% a year earlier.

Accounts receivable increased from approximately $445,000 at year end to $543,000, and inventory increased from approximately $430,000 to $562,000. Glow Q2 2026 financial statements, pages 3–4.

Those aren’t reasons for me to throw away the thesis.

They’re things to monitor.

O’Glove spends substantial time on receivables and inventory for precisely this reason. If those assets begin growing much faster than sales for an extended period, the balance sheet can be telling you something the headline revenue figure isn’t.

In Glow’s case, my current question is not:

“Are receivables and inventory increasing?”

They are.

My question is:

Are they increasing because the company is expanding distribution and preparing for higher sales, and do those balances subsequently convert into revenue and cash?

That is something future quarters can answer.

This is the part of Quality of Earnings I find most useful

The lesson isn’t that you should distrust everything.

It is that numbers need context.

Consider how differently these statements read once you ask one additional question.

“Happy Belly lost $4.6 million.”

Okay.

Why?

A large portion came from share-based compensation, alongside a $674,000 non recurring EHT charge associated with equity exercises.

“HBFG issued millions of shares.”

Okay.

Under what conditions?

Most of the original Phase 1 advisory warrants required the share price to first rise through performance hurdles extending to $2.00, after which exercising the securities put cash into treasury.

“Glow’s shares outstanding increased.”

Okay.

What happened to the capital structure?

More than 10 million warrants were exercised for cash, tens of millions more expired, and Glow ended Q2 with no warrants outstanding.

“Glow’s revenue increased 20%.”

Okay.

Did the economics improve?

Expenses declined, losses narrowed materially and quarterly operating cash flow crossed slightly positive.

That is what quality-of-earnings analysis is supposed to do.

It forces you to finish the sentence.

Canadian microcaps need one extra concept: Quality of Financing

If I were rewriting O’Glove’s book specifically for the TSX Venture and CSE, I would add an entire chapter called Quality of Financing.

Because early stage companies frequently need external capital.

That isn’t inherently bad.

The relevant question is:

What did the shareholder receive for the dilution?

If a company issues 10% more shares and uses the capital to build an asset that doubles sustainable free cash flow, the dilution may have been highly accretive economically.

If it issues 30% more shares just to fund recurring overhead for another year, that’s something else.

Likewise, warrants need context.

What is the strike?

What had to happen before they vested?

Who received them?

Was the company already creating value?

How much cash will exercise produce?

What does the fully diluted share count look like afterward?

And is the company’s per share economic value improving faster than the share count?

That’s the analysis.

Five things you can put into practice immediately

1. Read the statements before the news release. Start with the income statement, balance sheet and cash-flow statement. Form your own view first. Then read the MD&A and management’s release. The difference between what you noticed and what management emphasized is often where the most useful questions live.

2. Reconcile reported earnings to recurring economics. Identify share-based compensation, fair-value changes, disposition gains, impairments, one-time taxes, restructuring expenses and other unusual items. Don’t automatically remove them. Ask whether each item is cash or non-cash, recurring or non-recurring, and whether it represents a genuine economic cost to shareholders.

3. Treat dilution as a transaction, not just a percentage. Track basic shares, options, warrants, RSUs, convertibles and acquisition shares. Then ask what triggered the issuance, what exercise price was paid, how much cash entered treasury and what value was created before or after the dilution. HBFG’s performance warrants are a perfect example of why the structure matters.

4. Track operating leverage, not just revenue growth. Put revenue, gross profit, operating expenses and operating cash flow beside each other every quarter. Glow’s latest numbers are a good example: higher revenue and gross-profit dollars alongside lower expenses and shrinking losses tells you much more than “revenue up 20%.”

5. Ask one question after every quarter: “Did the business become economically better per share?” Not whether the stock rose. Not whether management beat guidance. Did recurring revenue improve? Did margins strengthen? Did cash generation improve? Did liquidity strengthen? Did the capital structure become cleaner? And after accounting for dilution, does each share plausibly represent more underlying economic value than it did before?

The bottom line

I don’t think the lesson from Quality of Earnings is that investors should become suspicious of every company they own.

The better lesson is that financial statements are a language, and the headline number is rarely the entire sentence.

A large IFRS loss can exist alongside strong underlying business growth. Revenue may be accelerating, recurring or higher quality revenue may be expanding, and compensation structures may be designed so that management benefits only after shareholders first see meaningful value creation. In some cases, the exercise of those incentives can also return cash to the company.

Likewise, a very small business can still show meaningful improvement even before it reaches profitability. Revenue growth accompanied by lower expenses, narrowing losses, improving liquidity, positive operating cash flow and the removal of financing overhangs can all indicate that the underlying economics are moving in the right direction.

None of this guarantees future success.

That is not what financial analysis can tell us.

What it can tell us is whether the evidence is moving in the direction required for the investment thesis to work.

And that is the habit that matters most in Canadian microcaps:

Don’t just ask whether the number is good or bad.

Ask:

Why did it happen?

Can it repeat?

What did it cost shareholders?

What did shareholders receive in return?

And ultimately:

Is the business underneath the number getting better?

That, to me, is the real meaning of quality of earnings.

Boosh Plant Based Brands was different.

Buried inside a crappy vegan stock trading for pennies was Beanfields, an established snack brand that had once generated approximately US$15 million in annual sales and had been carried in roughly 7,000 stores across North America.

That was precisely what made VEGI interesting.

That’s also what made the eventual dumpster fire so painful

WHY WE BOUGHT VEGI

TSA began buying VEGI around $0.02 in February 2023.

At that price, the market appeared to be treating Boosh as though almost nothing inside the company had value. Our thesis was that Beanfields alone could make that assumption wrong.

Boosh had acquired substantially all of the Beanfields assets in 2022. The company later described the purchase consideration as eight million Boosh shares, US$1 million of operating capital and a US$400,000 loan.

Management said Beanfields had produced approximately US$15 million in sales before the pandemic. Boosh also reported that Beanfields had historically reached thousands of retail locations and international markets.

That is an important distinction. The public disclosure supported approximately US$14.5 million in trailing revenue, not an independently appraised $14 million asset value.

The company had some debt but it was not a shell company trying to invent a product. It owned a recognizable consumer brand that had already demonstrated demand.

The opportunity appeared straightforward. Get the chips manufactured (3rd party) Improve, work on Margins, Get them back onto shelves. Stabilize distribution. Finance the working capital cycle. Let the existing brand do the heavy lifting.

At this time, there were multiple customers and companies asking about getting the chips back on the shelf.

At two cents, we did not need perfection. We needed basic corporate execution.

THE TRADE WORKED BEFORE THE INVESTMENT FAILED

The history needs to be told honestly.

VEGI was not an immediate loss for everyone.

The TSA trade log shows community purchases around $0.02 in February 2023. It also records trims between approximately $0.08 and $0.09, including members reporting substantial gains.

The stock produced a genuine multibagger move.

That matters because this was not a fabricated thesis attached to an assetless promotion. The market briefly recognized the possibility that Beanfields could be revived.

The mistake came later.

Some of us took profits and then returned. Others continued averaging down as the share price deteriorated. We remained focused on what Beanfields had been worth historically while the evidence increasingly showed that Boosh could not reliably fund, operate or report on the business.

We confused the potential of the asset with the capability of the company controlling it.

THE CAPITAL PROBLEM BECAME THE OPERATING PROBLEM

Consumer packaged goods businesses consume working capital and healthy margins.

Products must be manufactured before they are sold. Packaging, ingredients, freight, warehousing and retailer payment cycles all require cash. A brand can have demand and still collapse if the company cannot finance inventory.

Boosh acknowledged these pressures.

In early 2023, it completed a private placement that ultimately raised approximately C$362,000. It also announced multiple shares for debt transactions as creditors were paid with equity instead of cash.

The company issued millions of shares to settle obligations. Those transactions may have preserved liquidity, but they also demonstrated how constrained the balance sheet had become.

The problem was no longer simply getting Beanfields back into stores.

The company was settling creditors, borrowing to maintain public filings and looking for ways to continue operating.

Management announced partnerships, advisers and licensing arrangements. Each announcement offered another possible bridge to recovery.

But a bridge is only useful when it reaches the other side.

THE FILING FAILURES CHANGED EVERYTHING

Delayed financial statements were not an administrative footnote.

They were a warning that investors could no longer reliably measure the company’s condition.

Boosh received management cease trade orders related to late filings in both 2022 and 2023. The company later faced a broader cease trade order, and the Canadian Securities Exchange currently lists VEGI as suspended.

Once a company cannot produce current financial statements, the entire investment changes.

Investors cannot confidently determine what the company owns, what it owes, how much revenue is being recognized, how much cash remains or whether announced commercial activity is translating into shareholder economics.

At that point, the absence of reliable reporting becomes part of the operating thesis.

THE BEANFIELDS STRATEGY KEPT CHANGING

In August 2023, Boosh announced an exclusive United States licensing arrangement with Simple Yummy Chips. Boosh was to receive a royalty equal to seven per cent of the licensee’s cost of goods sold, subject to minimum sales targets.

The company also announced a line of credit of up to US$1 million for Beautiful Beanfields, carrying interest at 15 per cent annually.

Management presented this structure as a way to satisfy American demand without requiring Boosh to supply all the capital and resources itself.

Less than a year later, the strategy changed again.

In May 2024, Boosh and Simple Yummy Chips entered a nonbinding letter of intent contemplating the sale of the Beautiful Beanfields brand. Interim CEO Robert Hall said the potential divestment could reduce liabilities by approximately US$2 million and reduce the company’s capital burden.

That announcement revealed the central contradiction.

Beanfields was the asset that made the company interesting, but Boosh’s financial position made that same asset increasingly difficult to support.

WHERE MANAGEMENT LOST THE COMMUNITY

Shareholders can tolerate bad quarters.

They can tolerate difficult financings, imperfect launches and delays that are clearly explained.

What they cannot tolerate indefinitely is a widening gap between promises and execution.

Inside the TSA community, frustration became humour because humour was easier than repeatedly confronting the same disappointment.

Shareholders joked about product photographs, outdated samples, missed timelines and whether another announcement would ever produce something tangible. A remembered comment about Sundays being reserved for family became shorthand for what investors perceived as a lack of urgency.

Repeated capital constraints, extensive equity issuance, delayed filings, management changes, strategic pivots and an eventual trading suspension.

Our conclusion was not that Beanfields lacked potential.

It was that Boosh failed to convert that potential into a functioning, adequately financed and reliably reporting public company.

Connie Marples was the company’s founder and served as CEO during much of this period. She stepped down as CEO and director in April 2024, remained an adviser and was subsequently identified again as CEO in later company announcements.

Leadership changed. The fundamental questions did not.

THE COMPANY IS STILL ATTEMPTING A REVIVAL

The story has not technically ended.

In May 2026, Boosh said it had engaged an accounting firm to complete preaudit work and intended to file its outstanding fiscal 2024, 2025 and 2026 statements concurrently.

The company also reported that its American licensee, Tahoe Nutrition LLC, had processed approximately US$2.18 million in gross orders through a summer food program.

Processed orders should not automatically be treated as recognized Boosh revenue.

Boosh subsequently signed a nonbinding letter of intent to acquire Tahoe. The proposed consideration would leave the vendor holding approximately 50 per cent of Boosh’s fully diluted shares. Completion remains subject to due diligence, definitive documentation, regulatory and shareholder approvals, revocation of the cease trade order and resumption of trading.

That may eventually produce a viable recapitalization.

It may also produce substantial dilution for existing shareholders.

Until the audits are filed, the cease trade order is revoked and definitive agreements replace letters of intent, it remains a proposed rescue rather than a completed recovery.

THE REAL LESSON

The lesson from VEGI is not that distressed stocks should never be purchased.

At approximately two cents, the original setup offered a genuine asymmetric trade. Some investors successfully captured that move.

The lesson is that an asset thesis must eventually become an execution thesis.

A valuable brand cannot finance itself.

Historical revenue cannot manufacture current inventory.

Distribution history cannot replace working capital.

Press releases cannot replace audited statements.

And a recognizable product cannot protect shareholders from a company that loses control of its capital structure and reporting obligations.

We were right that Beanfields had value.

We were wrong to believe that value alone was enough.

Check the balance sheet, history of the team and remember CPG is capital intensive Regardless of whether you have third party fulfillment, the margins of a product mean more than the doors.

It’s better to have a thousand doors at a healthy margin versus 10,000 doors and burning cash.

AND NOW, A MESSAGE FROM THE PRODUCT DEVELOPMENT DEPARTMENT

This article would not be a proper VEGI autopsy without acknowledging the coping mechanism that got shareholders through it: satire.

Time For the Pivot, Beanfields Suppositories.

Possible side effects may include regret, confusion, sudden urges to check CEO.CA and the realization that a recognizable brand is not the same thing as a functioning public company.

.

The information is usually scattered across financial statements, regulatory filings, financing terms, management interviews, old announcements and thousands of investor conversations.

Most people see the headline.

Some read the news release.

Very few go back far enough or follow the company long enough to understand the complete story.

That information gap is where The Stock Avengers begins.

We are a completely free research community focused on Canadian small cap and micro cap companies that may be overlooked, misunderstood or too lightly followed by the broader market.

We do not promise to make every investment decision for you. We give you the history, evidence and questions needed to make better-informed decisions for yourself.

Subscribe now

Join the Free TSA Discord

The Problem Nobody Solves for Small Cap Investors

Large companies are followed by teams of analysts. Their conference calls are dissected, their estimates are updated and their histories are easy to retrieve.

Canadian small cap and micro cap investors often face the opposite problem.

A company may have limited analyst coverage. Important financing details may sit deep inside a filing. A management promise made three years ago may be forgotten. A seemingly impressive announcement may mean something very different once it is placed beside the company’s previous results.

The facts may be public, but that does not mean they are organized, understood or remembered.

Our purpose is to connect those facts before the market narrative replaces them.

What The Stock Avengers Actually Does

We build and maintain the research trail.

That means looking beyond the latest announcement and asking:

• Where did this company begin?

• What did management originally tell shareholders?

• How was growth financed?

• Who received shares, options or warrants and on what terms?

• Where did the cash go?

• Did the expected catalysts occur?

• Did operating results support the story?

• What has the market misunderstood or ignored?

• What would prove the investment thesis wrong?

These are not questions designed to produce automatic bullish or bearish conclusions. They are designed to produce a more complete one.

The Question at the Centre of Our Research

How will this decision and every dollar committed to it generate a return for shareholders?

We apply that question to acquisitions, debt, financings, executive compensation, capital expenditures and cash sitting on the balance sheet.

A friendly chief executive is not necessarily a skilled capital allocator. A growing business is not necessarily creating per share value. A large cash balance is only valuable if management protects it and deploys it intelligently.

We want to understand not only what management plans to do, but how each decision is expected to improve the outcome for shareholders.

The TSA Research Method

Our process is built around six steps.

1. Recover the original thesis. We identify what attracted investors before the company became widely discussed.

2. Build the timeline. We organize the announcements, financings, acquisitions, setbacks and milestones in the order they occurred.

3. Follow the capital. We examine how money and shares moved, what the company received and what shareholders surrendered.

4. Measure execution. We compare management’s statements with the company’s subsequent operating and financial results.

5. Challenge the narrative. We look for missing context, unresolved questions and evidence that contradicts the popular interpretation.

6. Update the conclusion. We explain what strengthened, weakened or invalidated the thesis as new information emerged.

This creates something a single quarterly result or news release cannot provide:

Memory, context and accountability.

What You Will Find on This Substack

• Long-form company research

• Financial statement and quarterly result reviews

• Management and capital allocation analysis

• Financing, dilution, option and warrant breakdowns

• Insider ownership and alignment reviews

• Acquisition and joint venture analysis

• Catalyst and operational progress tracking

• Follow up articles comparing expectations with results

• Lessons from investments that worked and those that did not

• Questions investors can take directly to management

We are not interested in simply rewriting a press release. We want to understand the economics underneath it.

Why the Substack and Discord Work Together

The Substack is the permanent research library.

It turns scattered information into structured articles that can be read, checked, shared and revisited.

The Discord is the active research floor.

It is where members share primary sources, challenge assumptions, track new developments and discuss other Canadian stocks as the evidence changes.

The article organizes what we know. The community keeps testing it.

Four Labels That Protect the Reader

Financial commentary becomes dangerous when fact, forecast and opinion are presented as though they mean the same thing.

Our research aims to distinguish among:

• Confirmed facts: information supported by regulatory filings, financial statements or official company announcements

• Management guidance: objectives and expectations communicated by the company

• Third-party forecasts: estimates published by analysts or other independent sources

• Community analysis: our interpretation of the evidence available at that time

If something is unknown, uncertain or still dependent on execution, it should be identified that way.

Good research does not eliminate uncertainty. It makes uncertainty visible.

What We Are Offering

We are offering independent research, an organized historical record and an open place to continue the discussion.

Readers can follow the Substack for structured articles and join the Discord for ongoing research, source material, questions and discussion about additional companies.

The best contribution is not agreement. It is relevant evidence that makes the collective understanding stronger.

What We Are Not Offering

We are not a registered investment adviser, brokerage firm or paid stock promotion service.

• No personalized financial advice

• No guaranteed returns

• No promises that price targets will be reached

• No claim that every featured company will succeed

• No premium room receiving research before everyone else

• No payment from readers for access to the work

Contributors may own shares in companies discussed, and those interests should be disclosed. Every investor must verify the information and make decisions appropriate for their own financial circumstances and tolerance for risk.

Why Is All of This Free?

Because an investor community becomes more valuable when thoughtful people can participate.

One member may understand financial statements. Another may know the industry. Someone else may recognize an experienced operator, find an overlooked filing or remember what management said several years earlier.

Put those perspectives together and the research becomes stronger.

There are no paid subscriptions, no pledges and no hidden premium tier.

The purpose is to build better-informed investors—not a subscription business.

Is This Community for You?

The Stock Avengers may be for you if you:

• Research Canadian small cap and micro cap companies

• Prefer primary sources over promotional summaries

• Want to understand management’s complete record

• Care about dilution, ownership and capital allocation

• Are willing to reconsider a thesis when the facts change

• Believe respectful disagreement can improve investment research

If you want certainty, guaranteed winners or someone else to make every decision for you, this is not that service.

If you want evidence, context and better questions, welcome.

What We Ask in Return

Read critically.

Check the sources.

Challenge conclusions with evidence.

Contribute what others may have missed.

Then make your own decision.

Follow the Research. Join the Conversation.

Canadian small cap companies often begin changing before the wider market begins paying attention.

Our objective is not to chase every price movement. It is to build enough knowledge that when something important happens, we understand what it means.

The market rewards execution, not presentation.

The Stock Avengers exists to document the story, measure the execution and help investors ask better questions before putting their own capital at risk.

Follow the free Substack to receive the structured research. Then join the free Discord to help continue it.

Subscribe now

Join the Free TSA Discord

Disclosure: The Stock Avengers publishes independent investor commentary for educational and informational purposes only. Contributors may own securities discussed in our articles. Nothing published here constitutes personalized financial, legal or tax advice or an offer or solicitation to transact in any security. Investing involves risk, including the possible loss of principal. Always verify information using primary sources and conduct your own due diligence.

With Happy Belly Food Group (CSE: HBFG; OTCQB: HBFGF), that question is not enough.

The more useful questions are:

• How much cash actually left Happy Belly’s bank account?

• How much consideration was paid in shares instead?

• Did the company buy an operating business, a franchising platform, or an option on something larger?

• Who funds the next store?

• Did Happy Belly obtain a contractual path to the remaining ownership?

• What became possible after the original deal that was not reflected in the original purchase price?

After reviewing the deal announcements, financial statements and years of discussion inside the Stock Avengers Discord, particularly the running analysis from Money and the explanations Sean Black provided, the pattern becomes difficult to miss.

Happy Belly has not simply been buying restaurants.

It has been assembling ownership, franchising rights, operating intelligence and future control, while repeatedly protecting its cash.

That is the 3D chess.

First, cash and shares are not the same thing

This distinction matters.

When Happy Belly issues $250,000 of stock to complete a transaction, the accounting value of the consideration is $250,000. But it does not mean $250,000 left the company’s bank account.

Shares still have a real economic cost: existing shareholders give up a portion of the company. That cost should never be dismissed. But issuing shares, transferring shares already held inside a joint venture, assuming liabilities and paying cash are four different things. Combining them into one number obscures the strategy.

The cleanest way to understand the acquisition record is to keep four separate ledgers:

1. Cash paid at closing

2. Shares issued or transferred

3. Liabilities assumed and transaction costs

4. Contingent consideration or future options

Using that framework, the major disclosed restaurant transactions look very different from a conventional cash funded acquisition spree.

The deal ledger

Heal Wellness: the prototype

On May 5, 2022, Happy Belly acquired 50% of Heal through a newly formed joint venture company. It subscribed for its half of the JV using 2,777,777 HBFG shares valued at $0.09 each, or $250,000. The founders contributed the Heal business, and Happy Belly received a call option on the remaining 50%.

Initial cash purchase price: $0.

The importance of the structure did not become fully visible until three years later. Heal grew from two locations to 20, and the company said trailing 12 month EBITDA had reached approximately $750,000. When Happy Belly exercised its option, the final disclosed purchase price for the remaining half was $3,896,948. It satisfied most of that amount by transferring the same 2,777,777 shares already held inside the JV, plus issuing 613,469 new shares.

The original shares had appreciated while the operating business grew. Happy Belly effectively used an asset created in the first transaction to help finance the second.

That is more than a cheap acquisition. It is a self reinforcing structure.

Source: Heal definitive call option agreement

PIRHO Fresh Greek Grill: the same playbook, repeated

Happy Belly closed its initial 50% acquisition of PIRHO on May 18, 2023. The company issued 1,562,500 shares, valued at $250,000, to the JV. The founding family contributed the franchising rights, brand assets and intellectual property, while Happy Belly secured an option on the other half.

Initial cash purchase price: $0.

In May 2026, Happy Belly exercised the option to acquire the remaining 50% at 7.5 times trailing EBITDA. Management said the payment would come from transferring the required portion of the HBFG shares already held by the JV, no cash and no newly issued shares, with final numbers expected at closing.

This is the Heal structure showing that it may be repeatable rather than accidental.

Sources: PIRHO original agreement and exercise of the remaining 50% option

Rosie’s Burgers: ownership plus a locked in path to control

Happy Belly closed its 50% acquisition of Rosie’s on November 13, 2023. Financial statements disclose 1,724,137 shares, measured at $250,000, as consideration.

Initial cash purchase price: $0.

The founders kept the other 50%, while Happy Belly obtained the right to acquire it under a predetermined formula. The founders therefore remained motivated to build EBITDA, while HBFG obtained the franchising platform and a future path to full ownership.

This alignment is a central feature, not a side effect. The seller’s remaining stake can become more valuable if Happy Belly’s platform works.

Sources: Rosie’s closing announcement and 2024 audited financial statements

Yolks Breakfast: a category entry without a cash cheque

Happy Belly completed its 50% investment in Yolks on January 29, 2024. It issued 904,856 shares, measured at $250,000, in exchange for half of the JV. The Yolks owners contributed the franchising rights, brand assets and IP.

Initial cash purchase price: $0.

Again, HBFG did not need to buy every restaurant outright. It acquired participation in the growth of the brand and the infrastructure through which future franchised locations could be developed.

Sources: Yolks definitive agreement and Q3 2025 financial statements

Via Cibo: buying an established franchise system with stock

Happy Belly acquired 100% of CraveIt Restaurant Group, operator of Via Cibo, in April 2024. The closing terms called for $450,000 of consideration shares plus $50,000 of working capital shares, priced at the 10 day VWAP. Most of the base consideration was restricted, and the agreement included a post closing earnout based on six times the change in EBITDA.

Cash purchase price disclosed at closing: $0.

The earnout mattered because it tied the ultimate price to delivered operating performance. If EBITDA increased, sellers participated; if it missed, the consideration could be adjusted, subject to the stated floor. Subsequent filings disclosed a $514,830 earnout obligation elected to be received in shares.

This was not a blank cheque. It was a performance priced acquisition.

Source: Via Cibo closing and transaction terms

IQ Food Co.: the clearest cash funded bargain

Happy Belly acquired 100% of IQ Foods and four corporate Toronto restaurants in September 2024. The court approved asset purchase agreement had an $85,000 purchase price, with restructuring, legal and transaction expenses bringing the company’s disclosed total acquisition cost to approximately $300,000 in cash.

This was a different type of deal: HBFG obtained operating locations rather than only a franchise platform. Management forecast approximately $4 million of system sales and $300,000 of EBITDA after corporate overhead at the time of closing.

Source: IQ Foods closing announcement

Smile Tiger Coffee Roasters: cash used where ownership and capability justified it

Happy Belly acquired 100% of Smile Tiger in January 2025 for $125,000 in cash plus $125,000 in shares. The purchase brought a corporate café, roasting capability, ecommerce and potential supply synergies across the broader portfolio.

Disclosed cash purchase price: $125,000.

The strategic value was broader than one store. It gave Happy Belly an entry into coffee and beverages, plus a possible internal supplier for a restaurant system that already consumes coffee across multiple brands.

Source: Smile Tiger definitive agreement

Salus Fresh Foods: fewer shares because the currency improved

Happy Belly closed its 50% acquisition of Salus in August 2025 by issuing 272,479 shares at $1.101, equal to $300,000. It also obtained a three year option to acquire the remaining half.

Cash purchase price: $0.

The timing illustrates another advantage of building the share price before closing. The announced dollar consideration remained $300,000, but a higher VWAP meant fewer shares were required. The acquisition added nine established locations in an fully franchised system.

Source: Salus closing announcement

Ghost Taco: the reputation transaction

The May 2026 Ghost Taco LOI may be the purest expression of the model.

Ghost Taco’s owners agreed to contribute the brand’s franchising system, intellectual property and related intangible assets to a new JV in exchange for their 50% interest. Happy Belly would receive the other 50%, plus optionality on the remaining half.

The public announcement did not disclose any cash or share consideration. Inside the community, Sean Black was asked directly about the omission and replied that all material terms had been disclosed and that cash or shares would have been disclosed if involved.

That supports the conclusion that the contemplated initial 50% interest required no disclosed cash and no disclosed HBFG shares, although the transaction was still at the binding LOI stage and final closing documents should be checked before treating it as complete.

Why would founders surrender half of a brand without a traditional purchase cheque?

Because they are not giving away half of what they already have. They are exchanging half of the future for a partner they believe can make the whole much larger.

The consideration is the platform: real estate relationships, franchising infrastructure, purchasing, accounting, marketing, operating experience, access to multi unit operators and credibility with landlords and franchisees.

That may be the strongest validation of Happy Belly’s intangible asset: its reputation as a scaler has itself become acquisition currency.

Source: Ghost Taco binding agreement

So how much cash has Happy Belly actually spent?

Across the major disclosed restaurant acquisitions reviewed above, the clearly identifiable cash paid or included in closing costs is approximately:

• IQ Foods: approximately $300,000 total acquisition cost

• Smile Tiger: $125,000 cash

• Heal initial 50%: $0 cash

• PIRHO initial 50%: $0 cash

• Rosie’s initial 50%: $0 cash

• Yolks initial 50%: $0 cash

• Via Cibo: all share consideration

• Salus initial 50%: $0 cash

• Ghost Taco initial 50%: no cash or shares disclosed in the LOI

That produces approximately $425,000 of clearly disclosed cash acquisition cost across these major transactions.

That is not the same as saying HBFG has spent only $425,000 building the portfolio. It has also funded payroll, systems, integration, corporate store capital expenditures, professional fees and working capital. Lettuce Love was acquired by assuming approximately $372,000 of liabilities, which was described as having no immediate out of pocket funding requirement but was still an economic obligation. Future option exercises and earnouts can also create additional consideration.

The defensible conclusion is narrower, and more powerful:

Happy Belly assembled most of its restaurant brand ownership through equity, contributed assets, performance based consideration and JV structures, while the directly identifiable cash cost of the major acquisitions above was only about $425,000.

That is capital allocation.

The five layers of the “3D chess”

1. Buy the platform, not every restaurant

When a franchisee funds and operates a new location, HBFG can earn franchise fees, royalties and potentially supplier rebates without funding the full construction cost of every store. The company’s capital can support the system instead of being trapped in every kitchen.

2. Let the founder keep meaningful upside

A 50/50 JV is not incomplete ownership when it is designed properly. It keeps the founder economically engaged while HBFG supplies capabilities the founder may not possess. Both parties win only if the brand grows.

3. Secure the option before proving the outcome

HBFG can work beside the founder, study store economics, test the partnership and help scale the brand before deciding whether to buy the remaining half. That is better information than an outside buyer normally receives during due diligence.

4. Use appreciating equity twice

Heal demonstrated the unusual power of placing HBFG shares inside the JV. The shares served as the initial consideration, appreciated as the company and brand developed, and later helped fund the purchase of the remaining interest. PIRHO is following a similar route.

5. Preserve cash for the moment when cash matters most

Cash is most valuable before the opportunity is known. Once it is committed, the company loses choices. By avoiding cash heavy acquisitions, HBFG retained the ability to act when a larger, cleaner or more strategic opportunity appeared.

The $12 million question

Happy Belly’s latest reported quarter confirms the number. At June 30, 2026, the company had approximately $12.0 million in cash and cash equivalents, compared with approximately $3.0 million one year earlier. Management attributed the increase primarily to options and warrants exercised during the first six months of 2026, alongside increased operating revenue, franchise revenue, services, interest income and rebates.

This is not a community estimate. It is the company’s reported Q2 2026 cash balance.

Where that cash came from matters

The $12 million was not created through a conventional brokered financing in which outside investors were offered discounted stock and the company paid commissions and broker warrants.

Much of it came from a shareholder aligned, performance based structure that had been developing for years.

During Phase 1, management, directors and consultants held warrants and options that required HBFG’s share price to reach predetermined performance levels before portions could vest. The disclosed milestones extended through $2.00 per share. Examples in the company’s filings show staged triggers at $0.50, $0.75, $1.00, $1.50 and $2.00, depending on the particular grant. The holders then had to exercise the vested securities by putting their own cash into the company.

The distinction is important:

• the rewards were tied to share price appreciation rather than granted solely because time passed;

• shareholders had to experience the price milestones before the corresponding incentives were earned;

• exercising the awards required insiders and other holders to contribute cash to treasury; and

• the resulting capital was raised without the customary broker commissions and broker warrants associated with a marketed financing.

On Jun

19, 2026, Happy Belly announced that 100% of the performance warrants and options expiring June 18 had been exercised. The company reported that officers, directors and consultants had exercised approximately 31 million performance options and warrants since January 2026, contributing $8.35 million directly to treasury.

That $8.35 million explains most of the increase behind the $12 million quarter end cash balance. The remainder reflects the company’s prior cash position and other movements in the business, including operating and franchise related receipts. It would therefore be slightly too broad to say every dollar of the $12 million came from performance warrants, but it is fair to say that the performance program was the principal driver of the increase.

In other words, Phase 1 produced two returns at the same time:

1. Shareholders benefited from the business and share price performance required to unlock the awards.

2. The subsequent exercises recapitalized the company from the inside, creating a much larger acquisition and growth war chest.

Sources: completion of Phase 1 and warrant exercises and Q2 2026 results

Phase 2: from $3 to $10

Phase 1 ended at the $2 level. Phase 2 raises the bar substantially.

The Phase II Executive and Board Compensation Plan covers 30 million securities: 12.125 million options and 17.875 million performance warrants, generally carrying $2.00 exercise prices, with performance vesting targets beginning at $3.00 and progressing at each dollar through $10.00 per share. The awards are not based on share price alone. The plan also refers to continued positive business performance, including year over year growth in royalty and franchise income and sustained positive adjusted EBITDA. Recipients must remain actively employed or serving on the board when the applicable milestones are achieved.

The ultimate deadline is October 3, 2030. According to the company, fully earning and exercising the Phase 2 awards would require HBFG shares to reach $10 and would result in executives and directors investing more than $60 million into treasury at the $2 exercise price.

That produces an unusually direct compact between leadership and shareholders:

The team does not receive the full economic benefit unless it first builds the business, meets the operating conditions and advances the share price through the stated milestones. It must then supply the exercise cash to turn those earned incentives into shares.

There is still dilution when options and warrants are exercised, and investors should account for it. But the other side of that dilution is substantial cash entering the company after performance conditions have been met. The relevant test is therefore not “Are more shares issued?” It is “How much per share value and future return can management create with the capital received?”

Phase 1 brought $8.35 million into treasury after the company progressed from its early turnaround price range to the $2 milestone. Phase 2 is designed to fund the next stage only if management creates another, much larger step change, from $3 through $10, while continuing to deliver the required business performance.

Source: Phase II Executive and Board Compensation Plan

The exact number on a given day matters less than what the balance sheet changes strategically.

With approximately $12 million available at quarter end, HBFG does not need to rush to spend it. Its value lies in the choices it creates:

• acquire remaining JV interests when the economics are compelling;

• close a larger, cash flow positive acquisition without depending on a financing window;

• selectively fund corporate stores offering high returns;

• support deposits, equipment, technology and infrastructure needed by a rapidly expanding franchise system;

• consolidate suppliers or capabilities that improve economics across every brand;

• move quickly when a distressed but attractive asset becomes available;

• withstand timing delays without negotiating from weakness; and

• avoid issuing equity when management believes the market price is unattractive.

These are possibilities, not announced uses of funds. That distinction is essential.

The best answer to “What will you do with the cash?” is not a rushed list of acquisitions. It is optionality governed by return thresholds.

Management should be judged on whether each dollar retained or deployed is expected to produce a better shareholder return than the alternatives, not on how quickly the cash disappears.

What the market may still be missing

The individual brands attract attention because they are visible. The deeper asset is the system connecting them.

Every successful opening strengthens the pitch to the next franchisee. Every capable franchisee can become a multi unit or multi brand operator. Every new brand gives landlords more concepts to place. Every additional restaurant can improve purchasing scale. Every proven JV makes the next founder more willing to exchange equity for access to the platform.

That creates a flywheel:

Better platform → better founders → better franchisees → more locations → stronger economics → more acquisition opportunities.

Ghost Taco matters because it suggests the flywheel may have reached a new stage. Early in the journey, Happy Belly used shares to attract brands. Now a founder may be willing to contribute 50% of a franchising system simply to gain access to Happy Belly’s people and platform.

The company’s currency is no longer only its stock.

It is its track record.

The bottom line

Calling these transactions “cheap” understates what happened.

Happy Belly repeatedly obtained an initial stake, preserved founder motivation, gained an inside view of the business, secured a route to control, outsourced much of the unit level growth capital to franchisees and kept its own cash available for higher return decisions.

Heal showed the model could work.

PIRHO suggests it can be repeated.

Ghost Taco suggests the model itself has become valuable enough to serve as consideration.

That is the 3D chess: not predicting one perfect move, but structuring the board so that several future moves remain available, and so that HBFG only has to commit major capital after the opportunity has become clearer.

The question for shareholders is no longer simply, “What brand will Happy Belly buy next?”

It is:

How much return can this platform generate from each dollar it does not have to spend?

This article is for educational and discussion purposes only and is not financial advice. Transaction figures are based on company disclosures available at the time of writing. LOIs, options, estimates and forward looking plans may change, and readers should verify final terms in HBFG’s filings and closing announcements.

Want to continue the discussion? Join the “HBFG Channel” in the Stock Avengers Discord for ongoing research, updates and analysis of HBFG:

Join The Channel

Not a generic warning about dilution. A company that diluted shareholders. Not a vague statement about patience. A stock where patience was rewarded. Not a textbook discussion about execution. A management team that either delivered or failed to deliver.

We reviewed the Stock Avengers archive from April 2021 through August 2026—290,217 public messages across 49 channels and selected ten stocks that produced ten distinct outcomes. We then checked the company names, tickers, transactions, and operating claims against company issued releases and filings. Prices and member outcomes are identified as observations from the Discord archive; company results are linked to the corresponding corporate disclosure.

1. Happy Belly Food Group (CSE: HBFG; OTCQB: HBFGF): Patience works when execution keeps validating it

The outcome

The Discord archive records TSA finding Happy Belly Food Group at approximately $0.10. It went on to become one of the community’s clearest long term successes.

This was not a four day spike or promotional trade. TSA watched management acquire and build brands, add locations, sign area development agreements, attract experienced multi-unit and multi franchise operators, improve system sales, and strengthen the balance sheet.

The company also endured a deeply painful period after Gary’s passing. The team had to grieve, retool, and carry on. It did. Sean and the broader team continued building focused on the legacy of Gary and the long term plan.

Rest in Peace, Gary Fung

Gone but never forgotten.
Your impact lives on.

By Q2 2026, HBFG reported $8.5 million in quarterly revenue, up approximately 57% year over year; $28.4 million in QSR system sales, up 75%; and 95 operating restaurants compared with 62 a year earlier. The company also reported approximately $12 million in cash. Figures and the exchange tickers are confirmed by HBFG’s Q2 2026 release

The lesson

Patience is not blind when the company keeps adding evidence.

HBFG taught us that a great long term investment does not need one spectacular catalyst. It can compound through acquisitions, openings, signings, financing decisions, and quarterly improvements. The reason to continue holding was not loyalty to the original call. It was that the operating story kept becoming more valuable.

2. KITS Eyecare (TSX: KITS): A strong business can outperform without a promotional story

The outcome

KITS Eyecare became a profitable pick for members who recognized the quality of the underlying business. The archive later included a direct acknowledgment that the idea had helped many people make money.

One revealing moment came during a secondary offering. Some investors saw the word “offering” and assumed dilution. The discussion correctly distinguished a secondary sale existing holders selling shares from a treasury financing in which the company issues new stock. KITS confirmed that it received no proceeds from the sale. The structure and ticker are verified in the company’s secondary-offering release.

KITS did not require a complicated turnaround narrative or binary regulatory outcome. It offered a growing operating company, an understandable consumer product, and numbers the market could evaluate.

The lesson

The simplest businesses can produce some of the cleanest wins.

KITS showed the value of understanding what a transaction actually is before reacting to its headline. It also reminded us that an investment does not need to be obscure or dramatic to work. Sometimes growth, execution, and a comprehensible business model are enough.

3. NorthStar Gaming Holdings (TSXV: BET; OTCQB: NSBBF): A successful trade is not automatically a successful investment

The outcome

The Discord archive records TSA becoming interested around $0.04 to $0.045 as the company discussed Canadian expansion and its BettorView relationship. The archive subsequently records a peak near $0.18 within four trading sessions a maximum move of roughly 350% from $0.04.

It later returned toward its original range and shortly after fell to shit.

Early traders who sold into strength had an exceptional opportunity. Investors who chased the move or treated the temporary price as permanent value experienced something entirely different. NorthStar’s ticker and the substance of the partnership are confirmed in its BettorView announcement.

The lesson

A spectacular price move and a durable investment are two different achievements.

BET taught us not to use a chart’s highest print as the return “the group made.” Entry, liquidity, position size, and exit determine the actual result. The trade worked brilliantly for some. The round trip showed why that fact alone did not make it a long term compounder.

4. Tetra Bio-Pharma (formerly TSX: TBP; OTCQB: TBPMF): Valuable science cannot save common equity from a broken balance sheet

The outcome

The original Tetra Bio-Pharma (TBP) excitement centred on regulatory submissions, clinical potential, intellectual property, and the value approvals might unlock. Early discussion also contained heavy momentum and promotional language.

Over time, financing became the dominant reality. On August 1, 2023, the company announced a voluntary assignment into bankruptcy under Canada’s Bankruptcy and Insolvency Act, and it was subsequently delisted from the TSX. The former tickers and bankruptcy are confirmed in the company’s bankruptcy announcement.

TBP has been gone for years and should not define modern TSA. Its relevance is one precise lesson not nostalgia and not an attempt to place today’s community under the weight of an historical painful lesson.

The lesson

The value of an asset and the value of the common shares are not the same thing.

Good science, patents, regulatory progress, and takeover possibilities mean little to shareholders if creditors and new capital stand ahead of them. The catalyst was never separate from the financing risk. Financing determined who would still own the catalyst if it arrived.

5. Simply Solventless Concentrates (TSXV: HASH): Revenue growth cannot compensate for weak integration and disappearing margins

The outcome

The initial Simply Solventless (HASH) thesis emphasized rapid growth, acquisitions, new brands, geographic expansion, and apparently inexpensive forward valuation. Then the structure began to fail.

An audit-driven revenue-recognition change removed approximately $4.3 million from reported 2024 revenue. Reported gross margin fell to roughly 13%, inventory became bloated, cash burn remained uncomfortable, and investors struggled to evaluate the acquired businesses clearly. The company had also added approximately 60 million shares during 2024.

Trust deteriorated alongside the financials. What initially looked like aggressive consolidation increasingly looked like businesses assembled faster than they could be integrated. In February 2026, three subsidiaries entered CCAA creditor protection and the stay was extended to a fourth subsidiary. That narrower wording matters: the proceedings involved the operating subsidiaries within a restructuring initiated by the public parent. The structure and ticker are confirmed in the company’s restructuring announcement.

The lesson

Acquiring revenue is not the same as building a business.

HASH taught us that reported growth can hide poor cash conversion, weak integration, margin deterioration, and balance sheet stress. Size did not protect shareholders when the economics underneath it were unstable.

6. Zoomd Technologies (TSXV: ZOMD; OTC: ZMDTF): Customer concentration can turn a record year into a credibility crisis

The outcome

Zoomd Technologies (ZOMD) initially looked exceptional: strong revenue growth, expanding margins, substantial operating cash flow, significant cash, and no major long-term debt. At one point, the archive described net income growth of roughly 150% and operating margins above 20%.

Then operating-model changes at two major customers changed the picture. Q4 2025 revenue fell 50% year over year, from $15.1 million to $7.5 million. Zoomd still reported $0.2 million in quarterly net income and ended 2025 with $22 million in cash and no long-term debt. Those figures, stated in U.S. dollars, are confirmed in Zoomd’s full-year 2025 release.

The setback did not make Zoomd worthless. Cash and a debt-free balance sheet provided resilience, while new clients created a possible recovery path. But the sudden change exposed a risk that the headline growth numbers had not made visible enough.

The lesson

The quality of revenue matters as much as its growth rate.

Customer concentration is not a footnote. When a small number of clients drive a large share of profit, one delayed budget or platform transition can transform the earnings profile. A strong balance sheet can buy time, but it cannot make concentrated revenue recurring.

7. EMERGE Commerce (TSXV: ECOM): A damaged company can become investable after the balance sheet changes

The outcome

EMERGE Commerce (ECOM) was once a larger but structurally weaker company carrying expensive debt and the scars of earlier expansion. The later thesis was not that the old model would suddenly return. It was that management had been humbled, sold non-core assets, reduced debt, preserved the business, accumulated cash, and refocused on profitable operations.

The archive followed a company with approximately $4 million in cash, a refinancing opportunity, and profitable assets. It also highlighted creative capital allocation: EMERGE sold the dormant SHOP.ca and SHOP.us domains to Shopify for approximately US$380,000, or C$540,000, and used those proceeds along with proceeds from another asset sale toward the Tee 2 Green acquisition. The exact transaction structure is confirmed by EMERGE’s acquisition release.

The turnaround was not complete, and a later equity financed acquisition reopened legitimate questions about dilution. But the business had become materially different from the one associated with its old share price and old mistakes.

The lesson

A thesis can improve because the balance sheet improves, even before rapid growth returns.

ECOM taught us to distinguish a broken stock from a permanently broken company. Selling assets, reducing debt, lowering interest expense, and improving cash generation can create value quietly. Turnarounds begin with survival and simplification, not exciting revenue forecasts.

8. Glow Lifetech (CSE: GLOW; OTCID: GLWLF): A healthier company does not always produce an immediate stock-market reward

The outcome

Glow Lifetech (GLOW) was added around $0.05, reached approximately $0.065, and later returned to roughly $0.045. Members who bought near $0.04 to $0.045 and sold into the return to $0.055 captured useful gains, while the longer price history remained largely sideways.

Underneath that price action, the company changed. Q2 2026 revenue increased 20% year over year, the company reported positive quarterly operating cash flow, and its remaining 8.9 million warrants expired unexercised, eliminating the warrant overhang. These claims and tickers are confirmed in Glow’s Q2 2026 release.

But Q2 2026 also showed the unfinished part: sequential revenue declined, EBITDA weakened, inventory increased, and first half operating cash flow remained negative. The better balance sheet removed an existential problem. It had not yet proven a self funding growth engine. However we expect Q3 to improve as we recently discovered Seasonality.

The lesson

Removing a major risk is not the same as creating a catalyst.

GLOW taught us that balance sheet repair can make an investment safer without making the stock move immediately. The company improved structurally, but the market still wanted sustainable revenue, EBITDA, and operating cash flow.

9. PharmAla Biotech Holdings (CSE: MDMA; OTC: MDXXF): A sector-wide regulatory event can overwhelm an individual thesis

The outcome

The PharmAla Biotech (MDMA) channel began as a temporary research and social channel rather than an official TSA pick. Some members traded the opportunity successfully, and the discussion explicitly encouraged people to take profits along the way.

The sector later confronted the FDA’s rejection of Lykos Therapeutics’ application for MDMA-assisted therapy for PTSD. PharmAla was not the applicant and did not receive that rejection. It is a separate company focused on clinical-grade LaNeo MDMA and novel MDXX molecules. The event nevertheless changed sentiment and the perceived commercialization path across the sector. PharmAla’s business description and tickers are confirmed in its corporate update.

Investors were not merely valuing sales or quarterly margins. They were valuing the probability that an entire treatment category would move through the regulatory system on the expected timeline.

The lesson

When the outcome is binary, position size matters more than confidence.

Deep research cannot eliminate regulatory risk. Investors can understand the science, supply chain, and opportunity and still lose if the decisive institution says no or asks for more evidence. A binary thesis can be intelligent, but it should never be mistaken for a predictable one.

10. Purebread Brands (TSXV: BRED): Sometimes the real investment begins after the original strategy fails

The outcome

Purebread Brands (BRED) inherited multiple unprofitable, cash-draining COHO locations and operational complexity. The investment case could not be evaluated honestly by pretending those problems did not exist.

The later story became one of restructuring: dealing with liabilities, changing leadership, concentrating on the Purebread bakery business, and pursuing a franchise-based expansion model. In March 2026, the company announced that approximately C$5.21 million owed to BMO had been purchased by an arm’s-length third party as part of a debt restructuring. The corporate name, ticker, and restructuring are confirmed by Purebread’s company release and the debt-restructuring announcement.

The outcome remains unfinished. Purebread has not yet earned the status of a completed turnaround. But it is no longer useful to analyze it as though the failed legacy configuration and the current operating plan are identical.

The lesson

A lower share price does not create a turnaround; a changed business does.

BRED taught us to separate evidence of restructuring from hope created by a cheap stock. Closing bad locations, reducing operational drag, and protecting per-share economics can establish the foundation. The rerating comes only if the remaining business proves it can generate durable profit.

Ten different outcomes

HBFG demonstrated that patience can create exceptional results when operating evidence compounds. KITS showed that understandable businesses and clean execution can outperform without drama. BET separated a great trade from a long-term investment. TBP showed that financing can erase the value of a catalyst for common shareholders. HASH exposed the danger of acquisition-led growth without integration. ZOMD revealed the hidden weight of customer concentration. ECOM showed how balance-sheet repair can revive an investment case. GLOW proved that becoming safer and becoming exciting are not the same thing. MDMA illustrated the power of binary regulatory outcomes. BRED showed that a turnaround must begin with a genuinely changed business.

The common lesson is not to become more bullish or more bearish.

It is to identify what kind of investment is actually in front of us.

This article is for education and discussion only. It is not investment advice. Microcap securities may be illiquid, volatile, promotional, and highly dilutive. Verify material claims using primary filings and conduct your own due diligence.

Want to discuss these case studies or research other Canadian stocks with the community? Join the Stock Avengers Discord. Thoughtful disagreement is welcome.

The first is looking at the balance sheet and pretending everything is fine.

It isn’t.

The second is looking at that same balance sheet, seeing the working capital deficit, debt and conclude.

This thing is going under. It is only a matter of when.

We disagree with both interpretations.

Purebread is still financially fighting.

But underneath the headline numbers, something important is happening:

The capital structure is being repaired.

That is the story right now.

Not explosive same store sales.

Not five new corporate locations next quarter.

Not some heroic revenue forecast.

At this stage, we care much more about whether Purebread making itself financially survivable, remove expensive obligations, stabilize the remaining operating business and create a capital structure from which growth eventually becomes possible.

And when we look at the numbers through that lens, the direction of travel is substantially better than the headline balance sheet suggests.

First, Let’s Admit What Is Still Ugly

At June 30, 2026, Purebread reported:

• $549,129 of cash

• $917,742 of current assets

• $17.823 million of current liabilities

• a $16.905 million working-capital deficit

• $26.416 million of total liabilities

• and negative shareholders’ equity of $8.750 million.

Those aren’t numbers we are going to sugarcoat.

The company remains highly leveraged.

Liquidity is thin.

And there is explicit going concern uncertainty.

If someone wants to argue that Purebread remains a high risk/high reward investment, we won’t argue with them.

Where we disagree is taking those facts and jumping directly to:

0 Star “Closing up Shop.”

Because once we start looking beneath the absolute liability number and examine what is happening to those liabilities, the picture changes substantially.

Follow the Direction, Not Just the Destination

Compare March 31 with June 30:

In one quarter:

Current liabilities declined approximately 14.9%.

Total liabilities declined approximately 11.3%.

The working capital deficit improved approximately 17.3%.

And the convertible debenture balance went from:

$1.650 million → $0.

That does not mean the balance sheet is amazing.

It means it is becoming less ugly.

And in a restructuring, that distinction matters enormously.

A company heading uncontrollably toward lights out, generally has a very different pattern:

liabilities compound, liquidity deteriorates, lenders tighten, creditors move toward enforcement, expensive debt becomes more expensive, and management increasingly loses control of the capital structure.

Purebread’s current trajectory is not nearly that simple.

MD&A outlines close to 10.5M in debt wiped out in the last 12 months, bulk of which done significantly above market at $1.25 conversions while the stock was trading at $0.15.

The Biggest Mistake Is Treating Every Liability as Static

A balance sheet is a photograph.

A restructuring is a movie.

If we freeze Purebread on June 30, we see approximately significant liabilities and a working capital deficit.

That is true.

But we miss the transactions occurring around that balance sheet.

And those transactions are the reason our view has changed.

Start With the Former BMO Debt

Purebread originally borrowed $5.5 million from BMO to help finance the Purebread Bakery acquisition.

By the time the facility was reassigned, approximately:

$5.210 million

was outstanding.

Importantly, BMO wasn’t merely another unsecured creditor.

The facility was secured by a first ranking security interest over Coho Acquisition Corp., the subsidiary holding Purebread Bakery.

BMO had demanded repayment.

That was genuine distress.

This was one of the strongest arguments behind an extremely bearish view of the company.

Then something changed.

An arm’s length third party lender acquired that BMO exposure.

The debt did not disappear.

Initially, the terms remained substantially intact.

So economically:

BMO → successor lender

not:

$5.2M debt → gone.

But then the successor lender did something much more interesting.

$3 Million of Secured Debt Is Being Moved Toward Equity

The successor lender subsequently agreed to settle:

$3,000,000

of the term-facility indebtedness through the issuance of:

• 20,000,000 common shares

• 10,000,000 warrants

• exercisable at $0.30

• for two years.

Let’s be very precise here.

As of the August 28 authorization date for the June financial statements, that transaction had not closed.

Therefore, the correct reported term-facility balance remains:

$5,188,606

not $2.19 million.

We are not going to give Purebread credit for debt that remains legally outstanding.

But we are also not going to pretend the agreement tells us nothing.

Because economically, something unusual is happening.

A secured creditor has a contractual claim ahead of common shareholders.

Yet this creditor has agreed, subject to closing, to exchange $3 million of that creditor claim for common equity and warrants.

That is a material change in risk.

The lender is moving from:

creditor

toward:

owner.

But it matters when evaluating the argument that informed capital expects the company to simply collapse.

Close to 10.5M in debt wiped out in the last 12 months, bulk of which done significantly above market at $1.25 conversions.

Think About the Alternative

This is where we think the “it’s going bankrupt anyway” thesis becomes too simplistic.

If the highest value outcome available to a secured creditor were obviously enforcement and liquidation, why voluntarily surrender a substantial portion of creditor seniority for equity?

Under Canada’s Bankruptcy and Insolvency Act, secured creditors have real enforcement tools. A secured creditor may apply for the appointment of a receiver, and that receiver can potentially take possession or control of substantially all property used in the insolvent person’s business. A secured creditor intending to enforce security over substantially all relevant business property is generally required to provide the statutory notice contemplated by section 244 before enforcement.

In other words:

Companies don’t simply “go under” because somebody looks at the current ratio and declares them dead.

There is a mechanism.

There are creditors.

There is security.

There are negotiations.

There can be enforcement.

There can be receivership.

There can be a proposal or restructuring.

There can, in appropriate circumstances, be proceedings under the Companies’ Creditors Arrangement Act.

The CCAA applies to qualifying debtor companies or affiliated debtor companies where total claims exceed $5 million. It is fundamentally a restructuring framework—not shorthand for “the business disappears tomorrow.”

And that is why creditor behaviour matters.

When a creditor with meaningful security negotiates an equity conversion instead of simply maximizing its debt claim, that is evidence worth examining.

It doesn’t guarantee the common shareholders win.

But it is very different from saying:

“The lenders are pulling the plug.”

They aren’t behaving that way today.

And the $3 Million Conversion Isn’t an Isolated Event

Another debt conversion actually did close during the quarter.

All being significantly above market

On April 30, Purebread completed a settlement involving approximately:

$1.975 million

of indebtedness.

The company issued:

• 1,579,670 shares

• 789,835 warrants.

The accounting evidence is visible directly on the balance sheet.

Convertible debentures:

March 31: $1.650 million

June 30: $0

That liability didn’t merely get discussed in a press release.

It disappeared from the balance sheet.

Existing shareholders paid for that through dilution.

But financial risk was also removed.

That trade off is central to understanding what is happening here.

Dilution Is Real. But Dilution Isn’t the Entire Analysis.

Purebread had approximately:

28.855 million shares

outstanding at March 31.

By June 30:

43.768 million.

That is approximately a:

51.7% increase in one quarter.

If the proposed $3 million settlement closes through another 20 million shares, the count would mechanically move to approximately:

63.8 million shares

before considering anything else.

That’s significant dilution.

We aren’t dismissing it.

But dilution has to be analyzed alongside what shareholders receive economically in return.

If a company increases its share count while leaving the exact same debt, cash burn and insolvency risk behind, that is destructive.

But if equity is issued to extinguish creditor claims and materially reduce the probability that the enterprise gets crushed by its capital structure, the calculation is different.

The relevant question is:

How much value per share is being surrendered versus how much enterprise risk is being removed?

Sometimes recapitalization destroys common shareholders.

Sometimes dilution is what allows common shareholders to survive at all.

The outcome depends on what happens after the restructuring.

There Is Still Bad Debt to Remove

We don’t want to swing too far in the other direction.

Purebread still has financing we would like gone.

At June 30, “other loans” totalled:

$1.844 million

across 11 small loans.

by June 30 because no principal was repaid during the quarter and additional fees accrued.

That is exactly the kind of financing we want to see eliminated.

There was also another loan previously carrying 3% interest per month. Purebread paid $350,000 in cash as part of a settlement, although the required one million shares had still not been issued when the financial statements were authorized, leaving a $406,004 carrying balance on June 30.

So no:

The cleanup isn’t finished.

How Much Conventional Debt Is Actually Left?

Excluding IFRS 16 lease liabilities for the moment, Purebread had approximately:

Debt / Loan June 30 Term facility $5.189M Other loans$1.844M Shareholder loans $337K Promissory notes$102K Convertible debentures $0Total~$7.473M

If the proposed $3 million term-facility conversion closes exactly as announced:

~$7.47M → ~$4.47M

before considering any other subsequent changes.

That is why closing that transaction matters so much.

It would not make Purebread debt free.

It would not magically fix working capital.

But it would represent another major reduction.

Even the Cash Burn Needs Context

Purebread reported operating cash flow of:

-$233,143

during the June quarter.

On the surface, that works out to approximately:

-$77,700 per month.

But approximately:

$472,448

of cash was absorbed through reductions in trade payables and accrued liabilities.

In plain English:

some of the negative operating cash flow resulted from paying old obligations down.

That is qualitatively different from losing $233,000 purely from operating the bakery business.

But we don’t want to manipulate the analysis in the opposite direction either.

Purebread also paid approximately:

$417,028

of lease obligations during the quarter and we will find out more on this.

Under IFRS 16, those payments sit in financing activities rather than operating cash flow.

So there are distortions both ways.

We don’t think there is enough clean evidence yet to declare a normalized monthly cash-burn number.

We need more quarters.

Yes, We Think More Capital May Be Required

This may be where our view differs from somebody trying to construct a purely bullish narrative.

We would not be surprised if Purebread raises additional capital.

In fact, looking at the current liquidity position and remaining obligations, we think investors should be prepared for the possibility.

That could mean:

• another equity financing;

• another debt conversion;

• a convertible;

• or some combination of fresh equity capital and additional debt restructuring.

And if it happens, our reaction will depend entirely on the economics.

Another financing is not automatically evidence that the restructuring failed.

The question is:

What does the new capital accomplish?

If Purebread raises money merely to fund continuing operating losses while the liability structure remains unchanged, we would become more concerned.

If capital comes in and removes another loan, eliminates remaining liabilities, strengthens working capital and gets the company materially closer to operations, we would view that very differently.

Again:

look beneath the transaction.

We’re Not Looking for Huge Growth Yet

This point is probably the most important part of our thesis.

We don’t think investors should be demanding massive growth from Purebread at this exact stage.

Management says the current seven corporate locations are producing approximately:

$14 million of run-rate revenue.

Great.

Now stabilize them.

Improve their economics.

Finish repairing the balance sheet.

Remove expensive financing.

Get the core operation sustainably cash-generative.

Then grow.

Trying to aggressively open corporate stores while sitting on a nearly $17 million working-capital deficit would make very little sense to us.

The company’s own filings acknowledge that existing obligations constrain capital spending and potentially expansion.

That is why the newly announced franchise model is interesting.

Not because we are building $250 million of future revenue into a spreadsheet today.

We aren’t.

But because franchising potentially changes who supplies the growth capital.

If franchise operators fund most buildout, equipment, staffing and location-level working capital, Purebread may eventually be able to expand without recreating the debt problem it is currently trying to escape.

We still need the economics.

Royalty rates.

Franchise fees.

Corporate capital requirements.

Lease guarantees.

Store-level EBITDA.

Commissary economics.

Until those are disclosed:

Franchising is plausible

Step Back and Look at the Entire Sequence

This is where the story starts making more sense.

Step 1: Shrink the weak footprint

Multiple commissary sites were transitioned or closed, followed by West 4th on March 31.

Step 2: Reduce operating costs

FY2026 operating expenses declined approximately 26% year over year.

Step 3: Recapitalize

Millions of dollars of debt have been converted, settled or renegotiated.

Step 4: Deal With BMO

The former BMO exposure moved to another creditor.

Step 5: Convert $3 Million of That Claim

That remains pending—but if completed, it materially reduces the largest conventional debt obligation.

Step 6: Eliminate the Remaining Expensive Financing

Still unfinished.

Step 7: Stabilize the Core Bakery

This is what the next several quarters need to prove.

Step 8: Grow Through a More Capital Light Structure

Potentially through franchisees rather than loading another collection of corporate-store liabilities onto the parent company.

That sequence is coherent.

Whether management successfully executes all eight steps remains uncertain.

But pretending no coherent restructuring exists is becoming increasingly difficult.

So What About the “Zero Star” Argument?

We understand on a surface level why somebody looking at Purebread historically could have reached an extremely bearish conclusion.

BMO had demanded repayment.

Liquidity was bad.

The company carried expensive financing.

The working capital deficit was enormous.

The balance sheet genuinely looked dangerous.

But investment analysis isn’t about defending yesterday’s rating forever.

When the facts change, the thesis has to be retested.

During this quarter alone:

• current liabilities declined $3.11 million;

• total liabilities declined $3.36 million;

• convertible debentures went to zero;

• other loans declined approximately $450,000;

• shareholder loans declined approximately $217,000;

• cash increased;

• and interest expense declined from approximately $648,000 to $355,000 year over year.

That doesn’t describe a healthy company.

But neither does it describe a company whose financial position is simply deteriorating unchecked.

The problems that originally justified severe skepticism are now being directly addressed.

That matters.

Our Base Case Isn’t Pretty

We aren’t forecasting a miraculous recovery.

Our working base case looks something like this:

The $3 million conversion closes.

The term facility drops toward approximately $2.19 million.

More expensive financing is removed or restructured.

There is probably additional dilution.

There may very well be another financing.

The seven location corporate footprint stabilizes.

The balance sheet gradually becomes less dangerous.

The underlying business gets closer to supporting itself.

And future expansion increasingly comes from franchise capital instead of Purebread continuously levering its own balance sheet.

In addition they sign agreements to open multiple new locations.

What Would Change Our Mind?

Being bullish does not mean constructing an argument that cannot be falsified.

There are several things that would make us materially more bearish.

The $3 Million Conversion Doesn’t Close

That is currently the single biggest restructuring proof point.

Revenue Continues Deteriorating

West 4th is already completely absent from the June quarter. The remaining footprint now needs to demonstrate stability.

Loans Stay on the Books

Repeated Financings Fund Operating Losses Instead of Repairing the Balance Sheet

That would be a very different pattern from recapitalization.

Purebread Starts Funding Aggressive Corporate Expansion Too Early

We would rather see survival and self sufficiency first.

Franchising Turns Out Not to Be Capital Light

If Purebread remains responsible for large buildout costs or significant lease obligations, the thesis changes.

We intend to watch them.

Where We Actually Land

We are bullish on the direction of the restructuring.

We are not bullish because Purebread suddenly has a beautiful balance sheet.

We are bullish because the ugly parts of that balance sheet are actually changing.

That distinction is everything.

Purebread has gone from a company facing a major bank repayment demand and an almost unmanageable creditor structure to one where millions of dollars of liabilities have been settled above market, converted or reduced and where the successor secured creditor has agreed to exchange another $3 million of debt for equity.

We care about what shareholders receive economically in exchange for that dilution.

If money starts disappearing into an operating business that cannot support itself while the debt remains unresolved, we will judge that accordingly too.

For now, however, the direction is clear.

But:

current liabilities are falling.

total liabilities are falling.

convertible debt has been eliminated.

other debt is being settled.

creditors are taking equity.

interest expense is declining.

the operating footprint has been rationalized.

And a potentially more capital efficient growth model is beginning to emerge.

And when we look underneath the headline balance sheet, we see something substantially more interesting than a company waiting to die.

We see:

a real operating business inside a balance sheet that is being structurally repaired.

We’re not asking Purebread to sprint yet.

We’re asking it to finish fixing the foundation.

Then we’ll worry about how fast it can run.

Join The TSA Discord for further discussion on this company

Then there are stocks that become misunderstood because everyone thinks the business is simple.

I believe Bridgemarq Real Estate Services may fall into the second category.

The ticker is BRE.

The company owns and operates some of the most recognizable real estate brands in Canada, including Royal LePage, Via Capitale, Proprio Direct and Johnston & Daniel.

So the immediate conclusion seems obvious.

Canadian housing is weak. Real estate transactions are down. Therefore Bridgemarq must simply be another leveraged bet on Canadian housing.

I think that interpretation misses what is actually underneath the company.

And the events of the past year may have made that misunderstanding considerably larger.

The Dividend Cut Changed the Shareholder Base, Not the Brands

Subscribe now

For years Bridgemarq was largely treated as an income security.

The company paid shareholders $0.1125 every month, equivalent to $1.35 annually.

Then on July 16, 2026, Bridgemarq effectively blew up that investment proposition.

Management announced that the annualized dividend would fall from $1.35 to just $0.05 per share.

The following trading day, BRE fell from $13.20 to $6.30, a decline of more than 52 percent.

In the weeks following it dropped more all the way to $3.72

That reaction makes perfect sense if you owned Bridgemarq principally because of the dividend.

The income proposition disappeared overnight.

But something else happened at the same time.

The underlying Royal LePage franchise network did not disappear.

The Via Capitale network did not disappear.

The company did not lose its trademarks.

Thousands of agents did not suddenly leave.

Its franchise agreements did not suddenly terminate.

Instead, the market capitalization collapsed because management decided that cash previously being distributed should remain inside the company.

That distinction is the beginning of my thesis.

Bridgemarq may have undergone a forced shareholder rotation.

The investors who owned BRE because it paid them every month suddenly had very little reason to continue owning it.

But the investors who might own BRE because of its brands, franchise economics, consolidation opportunities and potential capital allocation strategy had barely begun looking at it.

That creates an unusual situation.

The company changed faster than the shareholder base could.

Brookfield Was the First Clue

The dividend reduction did not happen in isolation.

There was an important event months earlier that I think deserves much more attention.

Brookfield Business Partners is Bridgemarq’s largest economic stakeholder through approximately 6.25 million Exchangeable Units of Residential Income Fund L.P.

These units create one of the most confusing parts of Bridgemarq’s financial statements.

They are recorded as a liability.

Their fair value moves with BRE’s share price.

When BRE’s share price rises, the accounting liability increases and Bridgemarq can report an accounting loss.

When BRE’s share price falls, the liability decreases and Bridgemarq can report an accounting gain.

None of that necessarily means cash entered or left the business.

Each Exchangeable Unit can ultimately be exchanged one for one into a Bridgemarq Restricted Voting Share.

That means investors need to be very careful about reading the Exchangeable Unit liability as if it were conventional bank debt.

It is not.

And Brookfield’s economic interests are therefore much closer to those of an equity owner than a conventional lender waiting to be repaid.

This became particularly important in October 2025.

Brookfield agreed that Bridgemarq could defer distributions owing on those Exchangeable Units for twelve months.

Brookfield also established an additional credit facility to give the company greater financial flexibility.

Think about the sequence.

First, Brookfield agreed to temporarily stop taking cash out of the business.

Bridgemarq continued paying its public shareholders.

Then, in July 2026, Bridgemarq dramatically reduced the cash being distributed to those shareholders as well.

Those decisions look very different when viewed together rather than independently.

The company appears to have progressively moved from distributing capital toward retaining capital.

And management has told investors exactly what it wants to do with that capital.

Debt reduction.

Franchise conversions.

Selective acquisitions.

Brokerage expansion.

Technology.

Artificial intelligence.

And participation in what management believes will be a period of significant Canadian real estate industry consolidation.

I don’t view the dividend reduction as the investment thesis.

I view it as the event that potentially exposed the investment thesis.

The Revenue Number Is Almost Backwards

One reason Bridgemarq is easy to misunderstand is that simply opening the income statement can lead you in the wrong direction.

In 2025, Bridgemarq reported approximately $407 million of total revenue.

At first glance that looks like a conventional real estate brokerage business.

It isn’t.

Brokerage Operations generated approximately $356.1 million of segment revenue.

Franchise Operations generated only about $55.3 million.

You could therefore conclude that the brokerage operation is overwhelmingly more important.

But now look at EBITDA.

Brokerage Operations generated approximately $4.1 million of segment EBITDA.

Franchise Operations generated approximately $26.0 million.

That is the business hiding inside the revenue statement.

The corporate brokerages produce enormous reported revenue because commissions flow through the operation.

But the margins are thin.

The franchise operation is entirely different.

It is an asset light network economics business.

Royal LePage and Bridgemarq’s other franchise brands collect recurring fees from agents and franchisees using the platform, brand, technology, marketing and infrastructure.

In 2025, roughly 86 percent of Bridgemarq’s positive segment EBITDA came from Franchise Operations despite that segment contributing only a small fraction of consolidated revenue.

That is the number I think investors should remember.

BRE is not primarily interesting because hundreds of millions of dollars of commissions move through its corporate brokerages.

It is interesting because sitting alongside those brokerages is a high margin franchise system involving one of Canada’s dominant residential real estate brands.

Royal LePage Is Much Larger Than Many Investors Seem to Realize

This became another part of the thesis that surprised me during the research.

Royal LePage isn’t some second tier Canadian real estate banner.

It is one of the country’s dominant networks.

An independent Canadian brokerage roster database currently tracks approximately 17,473 Royal LePage agents versus approximately 20,091 for RE/MAX and 9,373 for Century 21.

Sutton is much further behind at approximately 4,929.

Keller Williams, despite being a globally recognized American brand, represents only approximately 419 agents in the same Canadian dataset.

The dataset does not cover every REALTOR in Canada and shouldn’t be mistaken for an audited market share figure.

But the relative scale is difficult to ignore.

Royal LePage is effectively sitting beside RE/MAX near the top of the Canadian market while several brands many investors would instinctively place in the same category are materially smaller.

That matters because franchise businesses ultimately derive value from network scale.

The more durable the brand, the easier it becomes to recruit agents.

More agents generate more recurring franchise fees.

More franchisees strengthen the network.

Greater scale provides more resources for marketing, training and technology.

And those resources can make recruiting easier again.

It is a flywheel if management executes properly.

Then Something Very Interesting Happened to RE/MAX

This brings me to what may become the most important external catalyst for the thesis.

In April 2026, The Real Brokerage announced an agreement to acquire RE/MAX Holdings.

The stated enterprise value was approximately US$880 million.

The companies described that as approximately seven times 2025 EBITDA after incorporating anticipated synergies.

Before those synergies, the transaction valuation is closer to roughly 9.4 times RE/MAX’s reported 2025 EBITDA.

Those numbers matter to Bridgemarq for two different reasons.

The first is valuation.

A sophisticated acquirer just put a substantial enterprise value on a major real estate franchise system during one of the weakest housing environments in recent memory.

That doesn’t mean Bridgemarq deserves the same multiple.

RE/MAX is larger, international and structurally different.

But it does provide a useful market transaction demonstrating that franchise networks themselves have considerable strategic value independent of today’s housing transaction volumes.

That is important when Bridgemarq’s franchise operations generated approximately $26 million of segment EBITDA in 2025.

But I actually think the second implication may be more interesting.

Recruiting.

RE/MAX is now integrating with Real, a much younger technology driven American brokerage company.

That may work extremely well.

But major ownership transitions create uncertainty.

Franchise owners wonder what changes.

Agents wonder which systems survive.

Management structures change.

Technology platforms change.

Culture changes.

Economics can change.

Bridgemarq can offer something very different.

Royal LePage has operated in Canada for more than a century.

Its value proposition is stability.

For an independent brokerage owner deciding what banner to operate under for the next decade, that difference could matter.

And Bridgemarq management is explicitly retaining capital to pursue franchise conversions at exactly the moment significant competitors are undergoing structural change.

That is an interesting coincidence.

Perhaps it is only a coincidence.

Perhaps it is an opportunity.

Sutton Gives Us Another Valuation Clue

There is another Canadian transaction worth examining.

Sutton Group’s intellectual property and trademarks were purchased by Diversified Royalty Corp. in 2015 for approximately C$30.6 million and licensed back to Sutton under a long term royalty arrangement.

At the time, the royalty system included approximately 5,185 agents and initially generated roughly C$3.5 million annually.

That doesn’t provide a direct valuation for Royal LePage.

The structures are different.

The transaction occurred more than a decade ago.

And Royal LePage and Sutton are not equivalent networks.

But it demonstrates something important.

Real estate franchise brands and their underlying royalty streams are independently monetizable assets.

The brokerage transactions come and go.

The trademark, network and recurring franchise economics can have considerable standalone value.

Sutton itself changed ownership again in 2023 when Ross McCredie, through an acquisition company, purchased the operating company.

Meanwhile Royal LePage today operates at several times Sutton’s Canadian network scale.

That is the asset I think deserves more attention inside Bridgemarq.

What I Think the Market Is Seeing

I suspect many people encountering BRE for the first time see something like this:

Real estate company.

Weak Canadian housing market.

Falling revenue.

Debt.

Dividend eliminated for practical purposes.

Brookfield liability.

Stock collapsed.

Nothing interesting.

And if that were the complete picture, I would probably agree.

But I see something quite different.

I see one of Canada’s largest residential real estate franchise networks.

I see approximately $26 million of 2025 franchise segment EBITDA coming from about $55 million of franchise revenue.

I see a corporate brokerage business whose enormous revenue number obscures the economics of the much better franchise business beside it.

I see Brookfield holding approximately 6.25 million exchangeable units whose accounting treatment can badly distort headline earnings.

I see Brookfield voluntarily permitting its own distributions to be deferred before management subsequently reduced distributions to public shareholders.

I see a company redirecting tens of millions of dollars away from distributions and toward balance sheet improvement and growth.

I see a fragmented Canadian brokerage industry undergoing consolidation.

I see one major competitor being absorbed into an American technology platform.

I see weaker independent brokerages facing growing technology, compliance and operating costs.

And I see Royal LePage sitting near the top of the Canadian market with a brand that is exceptionally difficult to recreate.

That does not guarantee the investment works.

It does mean I think calling Bridgemarq simply a Canadian real estate stock substantially understates what investors actually own.

The Bear Case Still Matters

None of this removes the risks.

The dividend cut was enormous because the previous payout was enormous.

That alone tells you the old capital structure was not sustainable indefinitely under current operating conditions.

Canadian housing activity remains weak.

Agent counts declined materially following the departure of a major Royal LePage franchise.

Bridgemarq has meaningful conventional debt.

Free cash flow has weakened.

The corporate brokerage operations remain highly transaction sensitive.

Management now needs to prove that retained capital actually earns an attractive return.

This is critical.

Cutting a dividend does not create value.

Keeping cash does not create value.

Management creates value only if each retained dollar ultimately produces more than a dollar of incremental enterprise value.

If Bridgemarq simply accumulates cash, overpays for acquisitions or fails to translate industry disruption into franchise growth, the bullish thesis weakens considerably.

The next stage therefore needs to be measured rather than narrated.

I want to see franchise agreements increase.

I want to see agent recruitment stabilize and then grow.

I want to see debt decline.

I want to see evidence of attractive franchise conversions.

I want to see Franchise Operations EBITDA maintained or expanded.

And if management makes acquisitions, I want to see disciplined prices and measurable returns.

The dividend cut bought Bridgemarq financial flexibility.

Now management has to demonstrate what that flexibility is worth.

The Question I Keep Coming Back To

When someone tells me they looked at Bridgemarq and couldn’t find anything interesting, I understand how they arrived there.

If you look primarily at Canadian housing, the dividend cut and the headline financial statements, BRE doesn’t look particularly interesting.

But I think that is looking at the wrong asset.

The more interesting question is:

What is one of Canada’s largest and most recognizable residential real estate franchise platforms worth to a strategic buyer or long term owner?

RE/MAX now gives us one external reference point.

Sutton gives us another, much smaller Canadian reference point.

Bridgemarq’s own segment reporting gives us the economics.

And Royal LePage’s network scale tells us the asset is not insignificant.

For years BRE distributed much of the cash generated by that platform.

Today it is attempting to retain that capital and deploy it.

The market responded by taking the stock apart.

That may ultimately prove justified.

But it also created something that rarely existed while BRE was primarily viewed as a dividend security:

A price at which investors can stop asking what the dividend yields and start asking what the underlying franchise is actually worth.

That is why Bridgemarq interests me.

Not because I am making a heroic prediction about Canadian house prices.

Because I think the market may be pricing the wrong business.

Thanks for reading. You’re invited to join the Stock Avengers Discord for follow-up questions, ongoing discussion, and analysis of other stocks: https://discord.gg/tSKwUUgKDc

Educational research only, not individualized financial advice. Verify all figures independently and do your own due diligence.

The thesis in one sentence: ALCH is trading below its C$1.00 IPO price while the company is moving from years of validation into commercialization; the near-term issue is completing counterparties’ approvals and sign-offs, not a lack of operating activity.

The pullback since Alchemy Labs began trading is obvious. The more important question is what has happened inside the business during the same period.

Since the July IPO, Alchemy has expanded its ExoShield ULTRA Pro product coverage, signed a paid defence-development agreement and reported a significant improvement in second-quarter gross margin. That is not an absence of news. It is a company working through the period between technical validation and commercial conversion.

Our view is that the next phase depends on sign-offs. Programs involving large automotive fleets, original equipment manufacturers, defence suppliers and government organizations do not move at the speed of a small-cap stock chart. Internal approvals, technical milestones, contracting and counterparties’ timelines must be completed before Alchemy can announce definitive commercial outcomes.

That is why September and October matter. Those months are the next windows in which we expect some of this work to become visible. This is our expectation based on the due diligence assembled around the company—not formal timing guidance from Alchemy.

Disclosure: Members of the Stock Avengers community, including contributors to this due diligence, hold ALCH shares. No compensation was received for this article. This is not financial advice.

The IPO Price and the Operating Story Are Moving on Different Timelines

Alchemy completed its IPO on July 9, 2026, issuing 13,738,447 units at C$1.00 for gross proceeds of approximately C$13.74 million. Trading began on July 13.

The shares subsequently moved below the IPO price. That price action should not be ignored, but it should not be mistaken for evidence that the company stopped progressing.

Three notable disclosures followed the IPO:

• August 4: ExoShield added Ford F-Series coverage, expanding the ULTRA Pro portfolio to more than 20 vehicle models.

• August 13: Alchemy entered a paid non-recurring engineering agreement to advance Crypsis in Canadian defence textile applications.

• August 19: The company reported Q2 revenue growth, its first Crypsis revenue contribution and a substantially improved gross margin.

The market price declined during a period in which the company continued to issue operating updates. The gap is therefore not “news versus no news.” It is the difference between development news and the larger commercial sign-offs investors ultimately want to see.

What Alchemy Is Building

Alchemy is not a single-product story. It has two distinct commercialization platforms.

ExoShield: Automotive Protection

ExoShield develops windshield-protection films and related automotive coatings. Modern windshields increasingly include cameras, sensors and advanced driver-assistance systems, making replacement and recalibration more expensive for consumers, dealerships and fleets.

The commercial attraction of ExoShield ULTRA Pro is not only its protective performance. It is also the installation model.

According to the investor materials reviewed in our due diligence, ULTRA Pro can be installed substantially faster than traditional bulk windshield-protection films. A shorter installation can allow a shop to complete more jobs and potentially earn more gross profit per hour.

That matters because installers are not merely a distribution channel. If a product improves their economics, they have a direct reason to recommend and sell it. This is the installer-driven flywheel that makes the comparison to XPEL relevant: the product can scale partly because the people installing it are economically motivated to promote it.

The Q2 update showed tangible movement:

• The first six ExoShield ULTRA Pro aftermarket kit models were launched during the quarter.

• On August 4, Ford F-Series models were added.

• The portfolio had expanded to more than 20 vehicle models.

• Management said it expects to continue introducing additional kits.

The company has spent years building installer relationships, product knowledge and manufacturing capability. The IPO capital gives it additional resources to turn that foundation into a broader commercial rollout.

The Automotive Pipeline Is Larger Than the Current Revenue Base

Our due diligence identified several automotive and fleet opportunities discussed in company materials and management communications:

• Hertz: approximately C$60 million of annual opportunity

• SIXT: approximately C$20 million, with a Phase 2 pilot discussed

• Mercedes-Benz Buses: approximately C$7.2 million following a multi-stage qualification process

• New York City Transit: approximately C$2 million, associated with pilot activity

• U.S. Army Black Hawk follow-on work: approximately C$0.5 million

• VinFast: OEM discussions following the Mercedes-Benz validation work

These figures should be understood correctly. They are opportunity estimates, not booked revenue, signed purchase orders or guarantees.

But that distinction is also the point of the current setup. The market is waiting for one or more identified opportunities to move through final approvals and become a definitive commercial commitment. The pipeline does not need every opportunity to convert for the company’s revenue profile to look materially different.

A major reference customer could also change the quality of every conversation that follows. Automotive OEMs and fleet operators are conservative. Once a product has completed a lengthy qualification with a recognized organization, later discussions begin with an externally validated reference rather than an unproven claim.

Crypsis: From Validation Toward Commercial Integration

Crypsis is Alchemy’s thermal-signature-management platform for defence and security applications.

The technology is designed to reduce detectability across visual and infrared spectrums. More importantly, Crypsis is not limited to one finished garment or one piece of equipment. The nanoparticle-based coatings can potentially be integrated into textiles and rigid substrates, including uniforms, shelters, vehicles, aircraft-related surfaces and other defence equipment.

This creates a different scaling model from manufacturing every end product internally.

Alchemy’s strategy is to work with established defence manufacturers, suppliers and prime contractors. Those partners contribute application engineering, manufacturing capacity and access to procurement channels. Alchemy contributes the material technology, technical knowledge and intellectual property.

That model was visible in the August 13 NRE agreement.

Under the agreement, Alchemy and a Canadian textile-based systems manufacturer that supplies the Department of National Defence will collaborate on the integration of Crypsis into textile-based defence applications. The development work has an estimated total cost of C$250,000, with Alchemy compensated primarily for engineering and technical services.

The program is expected to proceed through three development phases. Advancement between phases depends on technical milestones and mutual agreement. If the work is completed successfully, the parties may negotiate a separate commercial agreement for production.

This is an important distinction:

• The technology has already undergone development and field validation with DND.

• Alchemy is being paid to complete application-specific engineering with an established supplier.

• The next step is a separate commercial production agreement.

The current stage is therefore not simply “more research.” It is the bridge between validated technology and a potentially repeatable product relationship.

Why the Sign-Offs Matter

A small public company can disclose its own progress. It cannot unilaterally announce a counterparty’s approval before documentation, technical milestones and commercial terms are complete.

That is the period ALCH appears to be in now.

The work can be active without being immediately reportable. Engineering can advance. Partners can test applications. Commercial teams can negotiate. Internal committees can review budgets and procurement. None of that becomes a definitive announcement until the required parties sign off.

This is why we do not interpret the post-IPO price decline as proof of an empty pipeline.

Our expectation is that September and October should begin clarifying which programs are ready to cross from activity into disclosure. The items we are watching include:

• Completion of milestones and sign-offs connected to the Canadian defence textile NRE

• Additional defence NRE agreements or prime-contractor programs

• Commercial progression involving Mercedes-Benz Buses

• Expansion of the SIXT pilot or movement in other fleet programs

• Further ExoShield ULTRA Pro model launches and installer adoption

• Evidence that the IPO-funded manufacturing and commercial expansion is increasing capacity

A delay in disclosure and a lack of underlying work are not the same thing.

Q2 Was a Pre-IPO Snapshot

Alchemy reported Q2 revenue of C$581,027, an increase of 16.9% from C$496,871 in the comparable quarter.

The composition is also worth noting:

• ExoShield generated C$509,195.

• Crypsis generated its first reported contribution of C$71,382.

• Gross profit was C$224,803.

• Gross margin improved to 38.7%, compared with a slightly negative gross margin in Q2 2025.

The operating loss increased as the company invested in engineering, sales, business development and infrastructure. However, the July IPO occurred after the June 30 quarter-end.

That timing matters. The Q2 balance sheet and income statement do not show a company that had a full quarter to deploy C$13.74 million of new gross proceeds. They show the business immediately before the capital intended to accelerate commercialization arrived.

Looking only at trailing revenue risks valuing Alchemy as though the IPO funded a continuation of the previous stage. The more relevant question is what the company builds with that capital after the quarter closed.

The Capitalization Misunderstanding

The IPO closing release reported 54,549,120 common shares issued and outstanding. It also reported that 14,722,612 common shares were held in escrow.

That post-closing figure is important because some discussion has treated pre-IPO convertible securities as though they remain an entirely separate future block to be added again. Our reading of the prospectus and post-IPO capitalization is that the closing share count already reflects the relevant conversion mechanics completed in connection with the listing.

The IPO units themselves included one common share and one-half warrant, with each whole warrant exercisable at C$1.50 until July 9, 2028, subject to the company’s acceleration right.

Investors should distinguish among:

• Shares already included in the reported post-IPO count

• Escrowed principal shares that release over time

• IPO warrants exercisable at C$1.50

• Future equity that would only arise if outstanding options or warrants are exercised

Treating the same conversion shares as both current shares and an additional future conversion can materially distort the capitalization analysis.

Two Independent Paths to Commercialization

The part of the ALCH thesis we believe is most underappreciated is the presence of two independent scaling engines.

ExoShield can grow through product availability, vehicle-model coverage, installer economics, dealerships, fleets, insurers and OEM programs.

Crypsis can grow through paid engineering, material sales, licensing and integration into products manufactured by established defence suppliers.

One platform does not need to wait for the other.

If an automotive sign-off takes longer, a defence program may advance first. If defence procurement moves slowly, ULTRA Pro kit adoption and fleet programs can continue progressing. Multiple commercialization paths reduce the dependence on one all-or-nothing announcement.

Management’s investor presentation outlined a 2027 revenue target of approximately C$19.54 million, divided almost evenly between ExoShield and Crypsis. The same due diligence also identified larger opportunities and non-dilutive funding applications that were not relied upon in that base case.

The significance is not that every pipeline number must become revenue. It is that the base case can be supported by more than one route, while a major commercial conversion could change expectations well before all associated revenue appears in the financial statements.

What September and October Can Tell Us

The next two months do not need to deliver every potential contract.

They need to show that the transition is continuing.

A paid NRE moving into its next phase, an additional defence agreement, a fleet expansion, an OEM sign-off or evidence of accelerating ULTRA Pro distribution would each provide information about the same central question:

Can Alchemy convert six years of technical work into recurring commercial revenue?

The IPO financed the attempt. The August updates showed that work is continuing. September and October should help investors judge the pace at which counterparties are completing the approvals required to make that work visible.

Final Takeaway

ALCH is below its C$1.00 IPO price. That fact is not being dismissed.

But the reason matters.

The company has not gone silent. Since listing, it has expanded the automotive portfolio, entered a paid defence-development program and reported improving revenue and gross margin. The larger opportunities are taking longer because commercial and defence programs require technical milestones, counterparties’ approvals and final sign-offs.

Our thesis is not that the stock must recover simply because it is below the IPO price.

Our thesis is that the market is currently pricing the wait while Alchemy is building the evidence required for commercialization.

The next meaningful information should come from execution: signed agreements, completed phases, expanded pilots, production commitments and continued product rollout.

September and October are the windows we are watching.

Sources

• Alchemy investor information

• IPO closing and post-IPO capitalization

• Ford F-Series and ULTRA Pro portfolio expansion

• Crypsis Canadian defence textile NRE agreement

• Alchemy Q2 2026 financial results

This article reflects our interpretation of public filings, company disclosures, investor materials and independent due diligence. Forward-looking opportunities are not guaranteed contracts or revenue. This is not financial advice.

Continue the Conversation

Join the free Stock Avengers Discord for ongoing ALCH discussion, follow-ups and analysis of other stocks:

https://discord.gg/tSKwUUgKDc

Prices are based on the August 28, 2026 close unless otherwise noted. NCIB means normal course issuer bid. Inclusion does not represent a recommendation or a prediction about future share-price performance.

At a Glance

• Capital returns and share repurchases: 8 companies

• Acquisitions and business combinations: 7

• Takeovers, redemptions and leadership changes: 3

• Restructurings and governance events: 5

• Smaller-cap developments: 5

Every company included this week was connected to an identifiable corporate event. Future price movement without a corresponding disclosure will receive a No Identified Catalyst tag.

Capital Returns and Share Repurchases — 8 companies

Solstice Advanced Materials — $SOLS | $63.53

Event types: Share Repurchase · Merger Termination · Guidance Reaffirmed

What happened: Solstice Advanced Materials announced a $500 million share-repurchase program after terminating its proposed merger with Element Solutions. The company also reaffirmed its financial guidance. SOLS shares gained approximately 12.8% following the announcement.

Next update: The timing and pace of repurchases, along with operating performance against the reaffirmed guidance.

Algonquin Power — $AQN | $5.66

Event types: Asset Sale · Debt Reduction · Portfolio Simplification

What happened: Algonquin agreed to sell its Chilean utility interest for approximately $126.5 million. The company intends to use the proceeds to reduce debt and support its existing capital plan.

Next update: Transaction closing, the application of the proceeds and future changes to the company’s debt position.

N-able — $NABL | $4.19

Event type: Share Repurchase Authorization

What happened: N-able added $50 million to its share-repurchase authorization, leaving approximately $95 million available under the program.

Next update: Actual repurchase activity rather than the size of the authorization alone.

Cineplex — $CGX.TO | C$11.92

Event type: NCIB

What happened: Cineplex renewed its normal course issuer bid, permitting the company to repurchase up to 10% of its public float.

Next update: How much of the authorization Cineplex uses and the average price paid for repurchased shares.

International Petroleum — $IPCO.TO | C$34.57

Event types: NCIB · Active Share Repurchases

What happened: International Petroleum continued purchasing shares under its existing repurchase program. Unlike a newly announced authorization, the company is already deploying capital through the program.

Next update: Weekly repurchase disclosures, production results and changes in commodity prices.

Norwood Financial — $NWFL | $34.15

Event type: Share Repurchase Authorization

What happened: Norwood Financial announced a new repurchase program covering approximately 5% of its outstanding shares.

Next update: Repurchase volume and the effect of the stock’s relatively limited trading liquidity.

Inter-Rock Minerals — $IRO.V | Approximately C$1.29

Event type: NCIB

What happened: Inter-Rock Minerals announced a repurchase program covering approximately 4.6% of its outstanding shares and 9.3% of its public float.

Next update: Actual purchase activity and trading liquidity.

Frontline — $FRO | $44.19

Event types: Special Dividend · Vessel Sale

What happened: Frontline plans to return a portion of its vessel-sale proceeds to shareholders through a special dividend of $0.80 per share.

Next update: The payment timeline, additional fleet transactions and tanker-market conditions.

Acquisitions and Business Combinations — 7 companies

Descartes Systems Group — $DSGX | US$81.84

Event type: Acquisition

What happened: Descartes acquired transportation-management software platform Tai Software for approximately US$100 million in cash. Tai provides an artificial-intelligence-enabled platform for freight brokers and logistics providers.

Next update: Product integration, customer retention and the acquired business’s contribution to revenue.

Diodes — $DIOD | $88.00

Event type: Acquisition Completed

What happened: Diodes completed its $250 million acquisition of ElevATE Semiconductor. The acquired business is expected to contribute approximately $50 million of revenue during its first year.

Next update: Integration progress and whether the acquired revenue develops in line with management’s expectations.

Exchange Income Corporation — $EIF.TO | C$121.64

Event type: Acquisition

What happened: Exchange Income agreed to acquire TerraPro for approximately C$30 million.

Next update: Closing conditions and how the acquired operation is incorporated into Exchange Income’s existing platform.

ONEOK — $OKE | $94.76

Event types: Acquisition · Financing · Debt Management

What happened: ONEOK announced an agreement to acquire Brazos Midstream assets for approximately $4.425 billion. The transaction includes Apollo-related financing arrangements and accompanying debt-management plans.

Next update: Financing details, transaction closing and the integration of the acquired assets.

Teva Pharmaceutical Industries — $TEVA | $36.44

Event types: Stalking-Horse Bid · Bankruptcy Asset Sale

What happened: Teva was selected as the stalking-horse bidder for BioXcel Therapeutics’ IGALMI and BXCL501 assets. A stalking-horse bid establishes an initial offer in a court-supervised sale and may be challenged by competing bids.

Next update: The bankruptcy auction, competing offers and the final purchase price.

WildBrain — $WILD.TO | Approximately C$1.69

Event types: Acquisition · Artificial Intelligence · Earn-Out

What happened: WildBrain acquired Personality AI using a combination of cash, shares and performance-based earn-out payments.

Next update: Earn-out milestones, integration and the commercial use of Personality AI across WildBrain’s character portfolio.

Real Brokerage — $REAX | $21.09

Event type: Business Combination Completed

What happened: The Real–RE/MAX combination was completed during the week, removing the transaction from the pending-deal stage.

Next update: Integration updates, operating targets and post-closing shareholder disclosures.

Takeovers, Redemptions and Corporate Actions — 3 companies

Jamieson Wellness — $JWEL.TO | C$45.55

Event type: Cash Takeover Offer

What happened: Kirin’s cash offer values Jamieson Wellness at C$45.75 per share. Based on the August 28 closing price, the spread was approximately 0.44% before costs. This is now primarily a transaction-closing situation rather than a conventional operating-company setup.

Next update: Regulatory approvals, closing conditions and the expected completion date.

Canaccord Genuity Series A Preferred Shares

Event type: Preferred Share Redemption

What happened: Canaccord Genuity’s Series A preferred shares are scheduled to be redeemed for C$25 per share on October 1.

Next update: The market purchase price, remaining distributions and the formal redemption timeline.

Gap — $GAP | $23.48

Event type: Executive Appointment

What happened: Gap appointed a new president and CEO for Old Navy.

Next update: Changes in merchandising, operating priorities and financial targets under the new leadership.

Restructurings and Governance Events — 5 companies

BioXcel Therapeutics — $BTAI | $0.1814

Event types: Chapter 11 · Court-Supervised Asset Sale

What happened: BioXcel Therapeutics filed for Chapter 11 protection and began a court-supervised process to sell substantially all of its assets. Debtor-in-possession financing is intended to fund the restructuring process.

Next update: Auction bids, court filings, creditor claims and the treatment of existing common shares under any restructuring plan.

Western Resources — $WRX.TO | Trading Suspended

Event types: CCAA Restructuring · Trading Suspension

What happened: Western Resources’ principal subsidiaries entered proceedings under Canada’s Companies’ Creditors Arrangement Act and obtained limited interim financing.

Next update: Court filings, additional financing, the restructuring plan and any update concerning the trading suspension.

Vision Marine Technologies — $VMAR | $7.65

Event types: Reverse Takeover · Non-Binding LOI

What happened: Vision Marine signed a non-binding letter of intent concerning a reverse takeover with an undisclosed defence company. Under the proposed structure, existing Vision Marine shareholders would hold approximately 2.9% of the combined company.

Next update: Identification of the counterparty, definitive transaction terms, financing requirements and the resulting share structure.

Better Home & Finance — $BETR | $13.85

Event type: Board Contest

What happened: Former CEO Vishal Garg is seeking to remove five directors and regain control of the company’s board.

Next update: Proxy materials, shareholder voting dates and any response from the existing board.

Element Solutions — $ESI | $34.93

Event type: Merger Termination

What happened: Element Solutions’ proposed merger with Solstice Advanced Materials was terminated without a breakup fee. ESI shares declined approximately 4.35% following the announcement.

Next update: Management’s revised capital-allocation strategy and any updated standalone outlook.

Smaller-Cap Quick Hits — 5 companies

• $CGD.V — Proposed royalty spinout: The company proposed spinning out a 5% net-smelter-return royalty. Next update: Final terms, shareholder approvals and the assigned royalty value.

• $GRG.V — Asset sale approval: Shareholders approved the San Pietro asset sale with approximately 98.8% support. Next update: Remaining closing conditions and the planned use of proceeds.

• $NUE.CN — Project LOI: The company announced a letter of intent for a large Alberta solar-and-storage project. Next update: A definitive agreement, financing, ownership terms and the construction timeline.

• $VGD.V — Property sale and NSR royalty: The company agreed to sell a non-core lithium property for cash and a retained royalty. Next update: Closing and future activity on the property.

• Alithya Group — $ALYA.TO — Asset acquisition: Alithya acquired project-management assets and added related personnel; financial terms were not disclosed. Next update: Additional disclosure and the expected revenue contribution.

Final Takeaway

The past seven days produced an unusually wide range of corporate activity.

Share repurchases and capital returns featured prominently, while several companies announced or completed acquisitions. Other situations moved into restructuring, board-contest or transaction-closing phases.

The purpose of this roundup is not to assign a positive or negative label to every announcement. It is to separate the event from the market reaction and provide a clear starting point for further research.

This recap is for informational purposes only and is not financial advice. Prices and transaction terms can change. Readers should review the original company disclosures before making an investment decision.

Continue the Conversation

Which catalyst deserves a deeper review?

Join the free Stock Avengers Discord for ongoing discussion, company follow-ups and analysis of other stocks:

https://discord.gg/tSKwUUgKDc

Bullish thesis: I went back through years of Happy Belly commentary to test whether the historical record supported the confidence I already had in management. What stood out was not perfection. It was consistency between what management said, how it aligned itself with shareholders, and what the business ultimately delivered.

There are dozens of ways to analyze a small cap company.

Revenue growth. EBITDA. Cash flow. Dilution. Unit economics. Same store sales. Acquisitions. Valuation.

But in Canadian microcaps, there is another variable that deserves more weight than investors often give it:

Can you trust management to do what they say they are going to do?

That sounds simple.

It is not.

Small cap investors are constantly sold the future. There is always another acquisition coming, another market opportunity, another transformational quarter, another presentation showing what the company could become.

The problem is that aspirations are cheap.

Execution is not.

That is why I wanted to look at Happy Belly Food Group differently.

Rather than starting with one quarter, one accounting adjustment, or one current concern, I went back through years of management commentary and asked a broader question:

Has the long term record actually supported what management has been telling shareholders?

Not whether every quarter was perfect.

Not whether every target landed exactly on schedule.

Not whether every acquisition worked flawlessly.

And certainly not whether you can find an individual line item in a financial statement worth questioning.

You always can.

The more important question is:

Over several years, have management’s actions remained congruent with its words, incentives and stated objectives?

After going through the history, I think the answer is clearly yes.

And that is important because management credibility is not established in a conference call.

It is established over years.

One Quarter at a Time

If there is one phrase that captures the early HBFG story, it is probably this one:

One quarter at a time.

Sean Black used variations of it repeatedly through 2023 and beyond.

In May 2023:

“Just be patient and watch us grow this thing one Q at a time.”

A month later:

“Just watch for Q2 FINS…one Q at a time.”

And later that year:

“No skipping bases we are working to build a real business.”

At the time, those were just words.

What matters is what followed.

The company began putting together a sequence of reported record quarters.

November 2022 marked its second consecutive record quarter.

April 2023 marked its third.

May brought the fourth.

August brought the fifth.

November brought the sixth.

The streak continued through 2024 and into 2025.

Eventually, what had sounded like an early stage CEO asking shareholders for patience became a measurable operating pattern.

That distinction matters.

Anyone can ask investors for time.

The credibility comes from what the business looks like after that time has passed.

With HBFG, each successive period increasingly left behind a larger operating platform than the one before it.

That does not prove the stock is cheap.

It does tell us that the operating direction management described was real.

Alignment Was Built Into Phase 1

One of the strongest parts of the HBFG story has been management’s emphasis on shareholder alignment.

And unlike a lot of microcap language around “skin in the game,” this was not merely rhetorical.

The original structure was built around performance warrants.

Management did not simply give itself a large block of free shares at distressed prices.

It invested capital.

It purchased shares.

And much of the meaningful upside had to be earned through predetermined share price thresholds.

Sean summarized the philosophy in November 2023:

“The reason we took ZERO FREE OPTIONS was to align ourselves with our retail shareholders…we only make real $$ when they do.”

That original incentive structure was effectively Phase 1.

The objective was ambitious at the time.

Management had performance warrants extending all the way to $2 per share, with tranches unlocking only as the share price progressed.

Sean repeatedly discussed those warrants publicly.

At $0.50, another tranche became relevant.

Later came $1.50.

Then $2.

And importantly, earning those warrants did not mean receiving free stock.

Management still had to write cheques into the company treasury to exercise them.

That distinction is fundamental.

The better the company performed, the more management earned the right to invest additional personal capital into the company.

If shareholders did not win, management did not receive the full economic benefit.

If management succeeded, the exercise of those warrants also brought additional capital into HBFG.

By early 2026, Sean described the original plan as a self funding mechanism that had been put in place years earlier.

That is exactly what eventually happened.

The Phase 1 warrants were exercised.

Millions of dollars flowed into treasury.

Insider ownership increased.

And the first major incentive cycle effectively reached completion.

That is a very different outcome from the typical microcap story where insiders receive cheap paper, sell it into liquidity, and then ask shareholders to finance the next chapter.

Phase 2 Resets the Alignment Higher

This is where the story becomes even more interesting.

Management did not reach the original objective and then abandon the incentive structure.

It effectively moved the alignment higher.

By late 2025, Sean was discussing warrants and options extending from approximately $2 to $10.

Then in February 2026, he described another block of performance warrants this way:

“1,000,000 Performance Warrants….at $2….they unlock from $3-$10.”

That is the beginning of what I view as Phase 2.

The first incentive structure was built around transforming a distressed microcap into a credible operating company and moving toward the original $2 objective.

The next incentive structure is tied to what happens after that.

$3.

$4.

$5.

And ultimately much higher levels if the company continues creating value.

That matters because it tells us something important about management’s incentives after Phase 1.

They are not simply aligned with preserving what has already been built.

They remain economically incentivized to build the next stage.

The target moved higher because the company moved higher.

That is exactly how I would want a long term incentive structure to evolve.

Phase 1 asked:

Can this team rescue the company, build a real operating platform and create substantial shareholder value?

The answer so far has been yes.

Phase 2 asks a much harder question:

Can the same team take a 100 location Canadian platform and build it into something materially larger?

That remains to be proven.

But once again, management’s economic incentives are tied directly to shareholders benefiting if they succeed.

Why This Matters More Than It Appears

This is also why I think investors can lose perspective when they become overly focused on individual accounting debates.

Questions around share based compensation matter.

Questions around salaries matter.

Questions around adjusted EBITDA matter.

Questions around dilution matter.

They should be analyzed.

But they should also be weighted properly.

There is a difference between identifying a legitimate accounting concern and allowing that concern to overwhelm four years of evidence regarding management behavior.

When I look at HBFG, I see a management team that established performance based incentives when the company was barely relevant.

I see those original incentives becoming valuable only after shareholders experienced substantial appreciation.

I see insiders then putting additional personal capital into the company to exercise them.

I see treasury being strengthened rather than drained.

And now I see the next compensation structure tied to substantially higher share price levels.

That does not make every criticism wrong.

It does make the larger alignment question much harder to dismiss.

The important point is not that management should never be questioned.

It should.

The important point is that investors should not mistake constant criticism for superior analysis.

Sometimes the most important conclusion comes from stepping back far enough to recognize the pattern.

And the pattern here is difficult to ignore:

Phase 1 alignment worked.

Management had to create shareholder value to earn its economics.

The company grew.

The share price moved.

The warrants were earned and exercised.

Capital flowed back into treasury.

And now Phase 2 begins with management once again incentivized at materially higher levels.

That is not noise.

That is structure.

And in my view, it deserves considerably more weight when judging management than an isolated accounting argument from a single quarter.

Join 3,000+ Canadian retail investors in the Stock Avengers Discord.

Continue the conversation, ask follow-up questions, dig deeper into the companies we cover, and see ongoing research, community DD, trade discussion, and analysis of other Canadian stocks.

The article is the research. The Discord is where the discussion continues.

Join Our Discord